quinoxalines has been researched along with varenicline in 801 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 256 (31.96) | 29.6817 |
| 2010's | 520 (64.92) | 24.3611 |
| 2020's | 25 (3.12) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, EP; Brooks, PR; Chambers, LK; Coe, JW; Davis, TI; Fox, CB; Heym, JH; Huang, J; Lebel, LA; Lu, Y; Mansbach, RS; O'Neill, BT; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Shrikhande, A; Tingley, FD; Vetelino, MG; Wirtz, MC | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; Gilbert, DG; Merikle, E; Olufade, AO | 2 |
| Camarelles Guillem, F | 1 |
| Coe, JW; Krueger, SS; Miller, S; O'Connell, TN; Obach, BJ; Obach, RS; Reed-Hagen, AE; Zandi, KS | 1 |
| Kuehn, BM | 7 |
| Corelli, RL; Hudmon, KS | 1 |
| Aveyard, P | 2 |
| Foulds, J | 1 |
| Carroll, FI; Luetje, CW; Mihalak, KB | 1 |
| Azoulay, S; Billing, CB; Gong, J; Gonzales, D; Nides, M; Oncken, C; Reeves, KR; Rennard, SI; Watsky, EJ; Williams, KE | 1 |
| Azoulay, S; Billing, CB; Gong, J; Hays, JT; Jorenby, DE; Reeves, KR; Rigotti, NA; Watsky, EJ; Williams, KE | 1 |
| Billing, CB; Hajek, P; Reeves, KR; Tonstad, S; Tønnesen, P; Williams, KE | 1 |
| Johnson, KC; Klesges, RC; Somes, G | 1 |
| Jones, C; Kirkpatrick, P; Niaura, R | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Gobey, JS; Smith, BJ | 1 |
| Keating, GM; Siddiqui, MA | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Fullerton, T | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M | 1 |
| Mogg, A; Peacey, E; Pullar, IA; Smith, JW; Szekeres, P; Tafi, E; Tricklebank, M | 1 |
| Schroeder, SA; Sox, HC | 1 |
| Kovacic, P | 1 |
| Dervaux, A; Kanit, M; Laqueille, X | 1 |
| Dimoulas, P; Mills, EJ; Wilson, K; Wu, P | 1 |
| Chambers, LK; Coe, JW; Glowa, J; Hurst, RS; Lebel, LA; Lu, Y; Mansbach, RS; Mather, RJ; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Tingley, FD; Williams, KE | 1 |
| Králíková, E | 1 |
| Kyle, JA; Zierler-Brown, SL | 1 |
| Siu, EC; Tyndale, RF | 1 |
| Cahill, K; Lancaster, T; Stead, LF | 5 |
| Bhattaram, VA; Bonapace, C; Chilukuri, DM; Duan, JZ; Garnett, C; Gobburu, JV; Jang, SH; Kenna, L; Lesko, LJ; Madabushi, R; Men, Y; Powell, JR; Qiu, W; Ramchandani, RP; Tornoe, CW; Wang, Y; Zheng, JJ | 1 |
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
| Tonstad, S | 2 |
| Blázovics, A | 1 |
| Coe, JW; Faessel, H; Obach, RS; Reeves, K; Reus, VI; Rollema, H; Watsky, E | 1 |
| Gonzales, D; Jorenby, DE; Reeves, KR; Rennard, SI | 1 |
| Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R | 1 |
| Frishman, WH | 1 |
| Evans, SE; Leischow, S; Nides, M; Sarna, L | 1 |
| Oberpichler-Schwenk, H | 1 |
| Martini, B | 1 |
| Billing, CB; Gong, J; Pennington, AM; Reeves, KR; Williams, KE | 1 |
| Bornstein, MM; Klingler, K; Ramseier, CA; Saxer, UP; Walter, C | 1 |
| Brixner, D; Dirani, R; Jackson, KC; Nahoopii, R; Said, Q | 1 |
| Vandemergel, X | 1 |
| Crane, R | 1 |
| Duh, D; Macken, E | 1 |
| Pipe, AL; Quinlan, B; Reid, RD; Riley, DL | 1 |
| Chambers, LK; Coe, JW; Hurst, RS; Rollema, H; Stahl, SM; Williams, KE | 1 |
| Garwood, CL; Potts, LA | 1 |
| Hudmon, KS | 1 |
| Tobin, ML | 1 |
| Hering, T | 4 |
| Bartlett, SE; Holgate, J; Richards, JK; Simms, JA; Steensland, P | 1 |
| Anthenelli, RM | 1 |
| Oehlke, KJ | 1 |
| Miller, MC | 1 |
| Kohen, I; Kremen, N | 1 |
| Freedman, R | 1 |
| Glover, ED; Rath, JM | 1 |
| Billing, CB; Cheng, HS; Cho, HJ; Hsueh, KC; Kim, CH; Tsai, ST; Williams, KE | 1 |
| Fujimoto, Y; Ishibashi, T; Maruyama, N; Nakamura, M; Oshima, A; Reeves, KR | 1 |
| Croghan, E | 1 |
| Ericson, JF | 1 |
| Arikpo, WB; Fergione, MB; Graul, TW; Johnson, BA; Macdonald, BC; Roy, MC; Timpano, RJ; Waterman, KC | 1 |
| Moorman, KL; Whitley, HP | 1 |
| Coffay, AO | 1 |
| O'Brien, CP | 3 |
| Lerman, C; Patterson, F; Schnoll, RA | 1 |
| Taéron, C | 1 |
| Brayman, TG; Burstein, AH; Clark, DJ; Faessel, HM; Grover, GS; O'Gorman, M; Obach, RS; Walsky, RL; Willavize, SA | 1 |
| Stack, NM | 1 |
| Burstein, AH; Clark, DJ; de Morais, SM; Faessel, HM; Feng, B; Obach, RS | 1 |
| Doggrell, SA | 1 |
| Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P | 1 |
| George, TP; Le Foll, B | 1 |
| Milbrandt, A; Ratcliffe, M; Smith, R; Spirling, LI; Stapleton, JA; Sutherland, G; Watson, L | 1 |
| Cohen, AF; Dubois, EA; van Bronswijk, H; Zitman, FG | 1 |
| Andrews, JO; Bennett, SM; Heath, JH | 1 |
| Cahill, K; Lancaster, T; Stead, L | 2 |
| Tønnesen, P | 3 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
| Billing, CB; Gong, J; Pennington, AM; Reeves, KR; Spangler, JG; Williams, KE | 1 |
| Carnahan, RM; Kennedy, WK; Kutscher, EC; Morstad, AE | 1 |
| Cooley, ME; Murphy, M; Sarna, L; Sipples, RL | 1 |
| Dougherty, PL | 1 |
| Aubin, HJ; Billing, CB; Bobak, A; Britton, JR; Gong, J; Oncken, C; Reeves, KR; Williams, KE | 1 |
| Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M | 1 |
| Bolin, K; Lindgren, B; Mörk, AC; Willers, S | 1 |
| Benowitz, NL | 2 |
| Stapleton, JA | 1 |
| Ebbert, JO; Hays, JT; Sood, A | 1 |
| Kristensen, PL; Pedersen-Bjergaard, U; Thorsteinsson, B | 1 |
| Asch, DA; Heitjan, DF; Lerman, C; Patterson, F; Ray, R; Rukstalis, M | 1 |
| Tyndale, R | 1 |
| Wonnacott, S | 1 |
| Dirani, R; Halpern, MT; Schmier, JK | 1 |
| Czogała, J; Goniewicz, ML; Koszowski, B; Sobczak, A | 1 |
| Gould, TJ; Gulick, D | 1 |
| Perno Goldie, M | 1 |
| Crawford, JT; Goldenberg, RL; Tolosa, JE | 1 |
| Brees, DJ; Cai, JH; Elwell, MR; Finkelstein, MB; Jakowski, AB; Sands, SB; Shen, AC; Tingley, FD | 1 |
| Baker, C; Boler, A; Howard, P; Knight, C | 1 |
| Billing, CB; Hays, JT; Jorenby, DE; Leone, FT; Niaura, R; Pappas, JE; Reeves, KR; Williams, KE | 1 |
| Popkin, MK | 1 |
| Bölcskei, PL; Walden, K | 1 |
| Rankin, KV | 1 |
| Ochoa, EL | 1 |
| Nelson, R; Pumariega, AJ; Rotenberg, L | 1 |
| Fatemi, SH | 1 |
| Miller, WA; Song, W | 1 |
| Chawla, PS; Kochar, MS | 1 |
| Kapoor, S | 1 |
| Fashner, J; Mayo, HG; Rao, S; Shah, ZH | 1 |
| Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Rohrbacher, KD; Troutman, MD; Willavize, SA | 1 |
| Rose, JE | 2 |
| Bhowmik, A; Hillman, T; Rajakulasingam, K | 1 |
| Glaser, PE; Rush, CR; Stoops, WW; Vansickel, AR | 1 |
| Evins, AE; Goff, DC | 1 |
| Chitkara, R; Krishna, G; Mohanasundaram, UM | 1 |
| Nadeem, SS; Pirmoradi, P; Roshan, S | 1 |
| Ferguson, SG; Shiffman, S | 1 |
| Hays, JT | 2 |
| McIntyre, RS | 1 |
| Freeman, A; Juncos, JL; Sullivan, KL; Zesiewicz, TA | 1 |
| Soares, C | 1 |
| Frøynes, W; Schjøtt, J | 1 |
| Delva, NJ | 1 |
| Reus, VI; Smith, BJ | 1 |
| Filip, M; McCreary, AC; Przegaliński, E; Stefański, R; Zaniewska, M | 1 |
| Tutka, P | 1 |
| Carroll, FI; Corrigall, WA; LeSage, MG; Ross, JT; Shelley, D | 1 |
| Gould, TJ; Lerman, C; Portugal, GS; Raybuck, JD | 1 |
| Frey, JM; Gur, RC; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, KA; Siegel, S; Strasser, AA | 1 |
| Bader, P; McDonald, P; Selby, P | 1 |
| Schunack, W | 1 |
| Brace, V; Danielian, P; Rore, C; Williams, D | 1 |
| Bird, ML; Vesta, KS | 1 |
| Ebbert, JO; Hays, JT | 2 |
| Catz, SL; Deprey, TM; Halperin, AC; Jack, LM; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Sillman, JS; Smetana, GW | 1 |
| Lyon, GJ | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Galanti, LM | 1 |
| Boyd, JW; Lasser, KE | 1 |
| Peiffer, G | 1 |
| Carrozzi, L; Pistelli, F; Viegi, G | 1 |
| Ericson, M; Löf, E; Söderpalm, B; Stomberg, R | 1 |
| Schroeder, SA | 1 |
| McEwen, A; West, R | 1 |
| Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M | 1 |
| Coe, JW; Guanowsky, V; Mineur, YS; Picciotto, MR; Rollema, H; Seymour, PA; Shrikhande, A | 1 |
| Einarson, A; Riordan, S | 1 |
| Caron, J; Duparc, A; Gosset, P; Lasek, A; Modiano, P | 1 |
| Florek, E; Piekoszewski, W | 1 |
| Chan, KP; Davies, S; Garza, D; Pothirat, C; Wang, C; Xiao, D | 1 |
| Cocores, JA; Gold, MS | 2 |
| Spirling, LI; Stapleton, JA; Sutherland, G | 1 |
| Cantrell, MA; Geraets, D | 1 |
| Collier, R | 1 |
| Tavares, AR | 1 |
| Groman, E; Homaier, I; Lichtenschopf, A; Tschabitscher, P | 1 |
| Goldstein, I; Korda, JB; Pfaus, JG | 1 |
| Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Cirimele, V; Evans, J; Kintz, P; Villain, M | 1 |
| Arora, G; Jain, M; Talwar, A | 1 |
| Faessel, H; Ravva, P; Williams, K | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR; Sood, A | 1 |
| Balchunas, E; Estevez, N; Harrison, EL; Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Petrakis, IL; Picciotto, MR; Shi, J; Tetrault, JM | 1 |
| Cornwell, J; Davis, JM; Gupta, S; Lajtha, A; Lindenmayer, JP; Noth, K; Sershen, H; Smith, RC | 1 |
| Broderick, M; Cantrell, L; Hedlund, AJ; Shah, N | 1 |
| Ebbert, JO | 1 |
| Arroyo, O; Brosa Riestra, M; Fernández de Bobadilla Osorio, J; Sánchez-Maestre, C; Sanz de Burgoa, V; Wilson, K | 1 |
| Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR; Whiteley, LB | 1 |
| Burke, MV; Ebbert, JO; Hays, JT; Hurt, RD | 1 |
| Fukuda, T; Igarashi, A; Takuma, H; Tsutani, K | 1 |
| Bergstrom, T; Guo, Y; Lv, Y; Xiao, Y; Zhang, X | 1 |
| Anghelescu, I | 1 |
| Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S | 1 |
| Silva, RR | 1 |
| Balvanz, TM; Magallon, HE; Mambourg, SE; Pham, RH; Purvis, TL | 1 |
| Ashby, CR; Callahan, PM; Gardner, EL; Li, X; Spiller, K; Tehim, A; Xi, ZX | 1 |
| Dugan, SE; Garrison, GD | 1 |
| Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P | 1 |
| Laine, P; Lindeman, S; Marttila, J | 1 |
| Diehl, A; Grosshans, M; Hermann, D; Mann, K; Mutschler, J | 1 |
| Stapleton, J | 1 |
| Laniado-Laborín, R | 2 |
| Bruguera, E; Ramon, JM | 1 |
| George, TP; Lising-Enriquez, K | 1 |
| Kasliwal, R; Shakir, SA; Wilton, LV | 1 |
| Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL | 1 |
| Bybee, K; Jones, PG; Lee, JH; O'Keefe, JH | 1 |
| Fidler, ME; Kashani, KB; Selby, MG; Shields, RC | 1 |
| Fegan, PG; Wood, SE | 1 |
| Kutscher, EC; Oehlke, K; Stanley, M | 1 |
| Heimlich, L; Steinberg, ML; Williams, JM | 1 |
| Attili, SK; Ferguson, J | 1 |
| Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K | 1 |
| Gooch, CL; Lynch, DR; Sullivan, KL; Zesiewicz, TA | 1 |
| Chapin, DS; Freeman, J; Guanowsky, V; Hajós, M; Hoffmann, WE; Horner, WE; Johnson, DE; Kozak, R; Majchrzak, MJ; McLean, S; Rollema, H; Seymour, PA; Williams, KE | 1 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Keiding, H | 1 |
| Bolin, K; Mörk, AC; Wilson, K | 1 |
| DiPaula, BA; Thomas, MD | 1 |
| Berlin, I; Hering, T; Jiménez-Ruiz, C | 1 |
| Faessel, HM; Rollema, H; Williams, KE | 1 |
| Franck, AJ; Sliter, LR | 1 |
| Booij, J; Crunelle, CL; de Bruin, K; Miller, ML; van den Brink, W | 1 |
| Arteaga, C; Hajek, P; Russ, C; Tonstad, S; Tønnesen, P | 1 |
| Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Abou-Zeid, E; Keyrouz, SG; Rudnicki, SA | 1 |
| Elia, D; Giucastro, G; Marangio, E; Mariano, ME; Olivieri, D; Scarascia, A; Tzani, P | 1 |
| Maritz, GS | 1 |
| Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J | 1 |
| Kranzler, HR; Oncken, CA | 1 |
| Frey, J; Gur, R; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, K; Siegel, S; Strasser, AA | 1 |
| Dupont, P; Gillet, C; Guerin, M; Guillaumin, C; Kalamarides, S; Larinier, E; Meignan, C; Moreau, A; Perriot, J | 1 |
| Liu, ME; Tsai, SJ; Yang, ST | 1 |
| Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L | 1 |
| Hind, D; Kenjegalieva, K; Peters, J; Tappenden, P | 1 |
| Clark, MM; Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Sood, A | 1 |
| Dufour, E; Gardier, AM; Maskos, U; Pons, S; Reperant, C; Rollema, H | 1 |
| Lavigne, JE | 1 |
| Batra, A; Friederich, HM | 1 |
| Faessel, HM; Gastonguay, MR; Ravva, P; Tensfeldt, TG | 1 |
| Cantrell, FL; Clark, AK; Clark, RF; Kreshak, AA; Ly, BT | 1 |
| Mafé, C; Tornero, C | 1 |
| Furberg, CD; Moore, TJ | 1 |
| Hao, W; Tan, L; Tang, Q | 1 |
| Adler, LE; Waldo, MC; Woodward, L | 1 |
| Booij, J; Crunelle, CL; Miller, ML; van den Brink, W | 1 |
| Mead, AN; O'Connor, EC; Parker, D; Rollema, H | 1 |
| Richins, C | 1 |
| Burke, MV; Ebbert, JO; Hays, J; Wyatt, KD; Zirakzadeh, A | 1 |
| Harrison-Woolrych, M | 3 |
| Ockene, I; Salmoirago-Blotcher, E | 1 |
| Arteaga, C; Benowitz, NL; Garza, D; Pipe, AL; Rigotti, NA; Tonstad, S | 1 |
| Jormanainen, V; Kotomäki, T; Linden, K; Linna, M; Sintonen, H; Wilson, K | 1 |
| Corelli, RL; Hudmon, KS; Prokhorov, AV | 1 |
| Anthenelli, RM; Arteaga, C; Heffner, JL; Lee, TC | 1 |
| Andersen, J; Kamens, HM; Picciotto, MR | 2 |
| Guillem, K; Peoples, LL | 1 |
| Papke, RL; Stitzel, JA; Wecker, L | 1 |
| Faessel, HM; French, JL; Gastonguay, MR; Ravva, P; Tensfeldt, TG | 1 |
| Keating, GM; Lyseng-Williamson, KA | 2 |
| Blak, BT; Hards, M; Maguire, A; Metcalfe, M; Wilson, K | 1 |
| Noda, K; Saku, K; Tsukahara, H | 1 |
| Mambourg, SE; Nelson, LA; Purvis, TL | 1 |
| Blumberger, D; George, TP; Ismail, Z; Syms, J | 1 |
| Allorge, D; Broly, F; Colombel, JF; Cortot, A; Jouet, JP; Torres, J; Tremblay, L | 1 |
| Benowitz, NL; Hukkanen, J; Ukkola, O | 1 |
| Bartlett, SE; Chatterjee, S | 1 |
| Gur, RC; Lerman, C; Loughead, J; Ray, R; Ruparel, K; Sanborn, P; Siegel, S; Wileyto, EP | 1 |
| Drach, L; Fox, V; Holbert, T; Maher, J; Saddler, LC; Schubert, S | 1 |
| Biala, G; Budzynska, B; Staniak, N | 1 |
| Davies, S; Flammer, M; Hughes, J; Russ, C; Tonstad, S | 1 |
| Barr, JD; Bevins, RA; Murray, JE; Reichel, CM | 1 |
| Fonte, CA; Lerman, C; Mercincavage, M; Perkins, KA | 1 |
| Bertrand, D; Bertrand, S; Coe, JW; Cremers, T; de Vries, M; Hurst, RS; Mather, RJ; O'Neill, BT; Rollema, H; Shrikhande, A; Tingley, FD; Tseng, E; Wang, EQ; Ward, KM; Williams, KE | 1 |
| Costa, E; Davis, JM; Guidotti, A; Lajtha, A; Maloku, E; Sershen, H; Smith, RC; Zhubi, A | 1 |
| Ainamo, A; Binnie, VI; Carr, AB; Fundak, A; Koeber, A; Koerber, A; Needleman, IG; Ohrn, K; Rosseel, J | 1 |
| Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, T; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Hayashi, K; Hori, H; Hoshuyama, T; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
| Beck, HN; Biazzo, LL; Campbell, SL; Froshaug, DB; Harwell, TS; Haugland, C; Helgerson, SD | 1 |
| Frey, JM; Jepson, C; Lerman, C; Patterson, F; Phillips, JM; Rudnick, ND; Siegel, SJ; Strasser, AA; Turetsky, BI | 1 |
| Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Baran, XY; Docherty, JP | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 2 |
| Biala, G; Staniak, N | 1 |
| Hays, JT; Lawrence, D; Lee, TC; Leischow, SJ | 1 |
| Burstein, AH; Fullerton, T; O'Gorman, M; Schwam, E; Zhao, Q | 1 |
| Hizue, M; Ishibashi, T; Nomura, S | 1 |
| Bhat, A; Crain, D | 1 |
| Chengappa, KN; Fonte, CA; Jain, A; Lerman, C; Mercincavage, M; Perkins, KA; Stitzer, ML | 1 |
| May, AC; Rose, D | 1 |
| Rollema, H; Tonstad, S | 1 |
| Dasher, D; Granko, RP; Groben, P; Isenstein, A; Lugo-Somolinos, A; Morrell, DS; Nicholas, MW | 1 |
| Fujimoto, Y; Hasunuma, T; Kikkawa, H; Maruyama, N | 1 |
| Ioannides-Demos, LL; McNeil, JJ; Piccenna, L | 1 |
| Ashton, J; Harrison-Woolrych, M | 2 |
| Lund, KE; McNeill, A; Scheffels, J | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Furberg, CD; Glenmullen, J; Moore, TJ | 2 |
| Cho, HJ; Davies, S; Fagerström, K; Lee, TC; Ma, W; Nakamura, M; Russ, C; Tsai, ST; Wang, C | 1 |
| Gardner, PD; Hendrickson, LM; Pang, X; Tapper, AR; Zhao-Shea, R | 1 |
| Akdag, ST; Cinemre, B; Doganavsargil, O; Metin, O | 1 |
| Ledford, H | 1 |
| Ruff, P | 1 |
| Zeller, A | 1 |
| von Garnier, C | 1 |
| Caldarone, B; Ghavami, A; Hackett, A; Hanania, T; Lowe, D; Min, W; Paterson, NE | 1 |
| Croghan, IT; Ebbert, JO; North, F; Schroeder, DR | 1 |
| Pelle, AJ; Smolderen, KG | 1 |
| Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC | 1 |
| Garelik, DA | 1 |
| Bergman, J; Desai, RI | 1 |
| Hays, JT; Lawrence, D; Lee, TC; Ma, W; Rennard, S; Tashkin, DP | 1 |
| Chen, CI; Harnett, J; Mastey, V; Patel, BV; Zeng, F; Zou, KH | 2 |
| Ayesta Ayesta, FJ; Minué Lorenzo, C; Olano Espinosa, E | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; Croghan, IT; Hays, JT | 1 |
| Choi, BW; Choi, JC; Jeon, EJ; Jung, JW; Kim, DK; Kim, JG; Kim, JY; Park, IW; Shin, JW; Yang, SY | 1 |
| Carroll, FI; Damaj, MI; George, O; Koob, GF; Lloyd, A | 1 |
| Tavares, AR; Volpe, FM | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
| Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM | 1 |
| Mineur, YS; Picciotto, MR | 1 |
| Anderson, KD; Campbell, AR | 1 |
| Gnegy, ME; Jutkiewicz, EM; Kim, MN; Zhang, M | 1 |
| Beard, SM; Samuel, M; Wilson, K; Zimovetz, EA | 1 |
| Johnson, TS | 1 |
| Agboola, S; Coleman, T; Leonardi-Bee, J; McEwen, A; McNeill, A; Taylor, M | 1 |
| Burstein, AH; Faessel, HM; Obach, RS; Ravva, P; Rollema, H; Williams, KE | 1 |
| Flik, G; Folgering, JH; Lee, TC; Rollema, H; Wilson, GG | 1 |
| Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G | 1 |
| Lilja, AM; Marutle, A; Nordberg, A; Porras, O; Storelli, E | 1 |
| Booij, J; Crunelle, CL; de Bruin, K; Miller, ML; Schulz, S; van den Brink, W | 1 |
| Fagerström, K; Gilljam, H; Messig, M; Metcalfe, M; Tonstad, S | 1 |
| Lancaster, T; Stead, L | 1 |
| Asano, A; Hasegawa, M; Katsura, H; Kiguchi, T; Nagai, A; Nozu, T; Onizawa, S; Saiki, K; Taniguchi, H | 1 |
| Balmford, J; Borland, R; Cummings, KM; Hammond, D | 1 |
| Cunningham, CS; McMahon, LR | 2 |
| Giwa, TA; MacSuibhne, S; McCauley, MD | 1 |
| Childress, AR; Cruz, J; Detre, JA; Franklin, T; Goldman, M; Hazan, R; Li, Y; O'Brien, CP; Suh, JJ; Wang, Z | 1 |
| Walsh, RA | 1 |
| Fucito, LM; O'Malley, SS; Romano, DM; Tek, E; Toll, BA; Wu, R | 1 |
| Campos, C; Huang, LZ; Ivy Carroll, F; Ly, J; Quik, M | 1 |
| López, AR; Vasco, PG | 1 |
| Allan, GM; Els, C; Ivers, N | 1 |
| Weinsier, ST | 1 |
| Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C | 1 |
| Crespel, A; Gelisse, P; Serafini, A; Velizara, R | 1 |
| Boudrez, H; Gratziou, C; Messig, M; Metcalfe, M | 1 |
| Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ | 1 |
| Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, A; McNeill, A; Rivard, C | 1 |
| Ebbert, J; Erwin, PJ; Montori, VM; Stead, LF | 1 |
| Bush, T; Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| De Vries, TJ; De Vries, W; Pattij, T; Riga, D; Schetters, D; Schoffelmeer, AN; Stegeman, M; van Mourik, Y; Wouda, JA | 1 |
| Enea, D; Ferketich, AK; Grassi, MC; Lu, B; Nencini, P; Pasquariello, S | 1 |
| Catz, SL; Deprey, M; Jack, LM; Javitz, HS; McAfee, T; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Grief, SN | 1 |
| Dong, E; Guidotti, A; Kadriu, B; Maloku, E; Pibiri, F; Satta, R; Zhubi, A | 1 |
| Buchanan, RW; Buchholz, A; Coffay, A; Kelly, DL; Liu, F; McMahon, RP; Weiner, E | 1 |
| Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A | 1 |
| Bartlett, SE; Bito-Onon, JJ; Chatterjee, S; Holgate, J; Simms, JA | 1 |
| Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Guwanardane, N; Hussain, S; Kayne, E; Petrides, G | 1 |
| Kelsall, D | 1 |
| Bangpattanasiri, K; Rujiraruchana, K; Sangsayunh, P | 1 |
| Caro, JJ; Davies, S; Ishak, KJ; Kinter, ET; Marton, JP; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Kotz, D; van Schayck, OCP | 1 |
| Francois, D; Kotbi, N; Odom, A | 1 |
| Caldarone, BJ; Cavino, K; Chellappan, SK; Fedolak, A; Ghavami, A; Hanania, T; Kozikowski, AP; Kwan, M; Manzano, M; Olivier, B; Paterson, NE; Picciotto, MR; Wang, D | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Nazir, N; Nollen, NL; Owen, A; Pankey, S; Thompson, N | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Severson, HH | 1 |
| Gur, RC; Lerman, C; Loughead, J; O'Donnell, GP; Ray, R; Ruparel, K; Senecal, N; Siegel, S; Wileyto, EP | 1 |
| Davies, D; Dresler, C; Hilgenberg, J; Japuntich, S; Lanuti, M; Pandiscio, J; Park, ER; Rigotti, NA; Temel, J | 1 |
| Dhanji, AR; Hajek, P; McRobbie, HJ; Myers, KE; Stapleton, J | 1 |
| Simon, JA | 1 |
| Gallagher, T; Haseler, CA; Hirschhäuser, C | 1 |
| Aubin, HJ; Karila, L; Reynaud, M | 1 |
| Bircher, R; Chen, W; DiFranza, JR; Heffernan, M; Huang, W; King, J; Rane, P; Shields, J | 1 |
| Fidler, JA; Kotz, D; West, R | 1 |
| O'Malley, SS | 1 |
| Brandon, TH; Drobes, DJ; Heckman, BW; Karver, SB; Oliver, JA; Roetzheim, RC; Small, BJ; Unrod, M | 1 |
| Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M | 1 |
| Coleman, T; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Beebe, LA; Choi, WS; Cully, L; Daley, CM; Faseru, B; Greiner, AK; Kaur, B; Shireman, TI; Talawyma, M; Yeh, HW | 1 |
| Bergen, AW; Catz, SL; Conti, DV; Deprey, M; Hinds, DA; Jack, LM; Javitz, HS; McAfee, T; McClure, JB; Michel, M; Richards, J; Stokowksi, RP; Swan, GE; Wessel, J; Zbikowski, SM | 1 |
| Lawrence, D; Lee, TC; Marton, JP; Rennard, S; Tashkin, DP; Taylor Hays, J | 1 |
| Abreu, P; Bolliger, CT; Chopra, P; Correia, EA; Issa, JS; Park, PW; Posadas-Valay, R; Safwat, T | 1 |
| Chen, MC; Jeang, SY; Liu, ME; Peng, SL; Tsai, SJ; Tsai, YL; Wu, SL; Yang, ST | 1 |
| Foulds, J; Gandhi, KK; Steinberg, MB; Steinberg, ML; Ulpe, R; Williams, JM | 1 |
| Callas, PW; Fagerstrom, KO; Fingar, JR; Hughes, JR; Rennard, SI; Talbot, SK | 1 |
| Belcon, AL | 1 |
| Ari, H; Ari, S; Bozat, T; Celiloğlu, N; Coşar, S; Doganay, K | 1 |
| Bigman, C; Cappella, J; Leone, F; Lerman, C; Patterson, F; Pinto, A; Schnoll, RA; Wileyto, EP | 1 |
| Carlini, SV; Dutra, SJ; Evins, AE; Pizzagalli, DA; Stoeckel, LE | 1 |
| Marti, J | 1 |
| Furberg, CD; Loke, YK; Singh, S; Spangler, JG | 1 |
| Brooks, EA; Jutkiewicz, EM; Kynaston, AD; Rice, KC; Woods, JH | 1 |
| Stevens, KE; Wildeboer-Andrud, KM | 1 |
| Bencherif, M; Lester, HA; Lummis, SC; Thompson, AJ | 1 |
| Carpenter, MJ; Gray, KM; Klintworth, EM; Lewis, AL; Upadhyaya, HP | 1 |
| Buchanan, RW; Fuller, RL; Heishman, SJ; Hong, LE; McMahon, RP; Myers, C; Nye, A; Rachbeisel, J; Summerfelt, A; Thaker, GK; Wonodi, I; Yang, J | 1 |
| Jones, DL; Rankin, KV | 1 |
| Carson, JL; Greenhaus, S; Randall, J; Richardson, DL; Schmelzer, AC; Steinberg, MB | 1 |
| Casiano, EM; Claveria, AM; Escoto, L; Park, PW | 1 |
| Annemans, L; Diaz Cerezo, S; Hettle, R; Ines, M; Lopez de Sa, E; Marbaix, S; Prignot, J; Santoni, L; Wilson, K | 1 |
| Czoty, PW; Gould, RW; Nader, MA; Nader, SH | 1 |
| Arteaga, CE; Hughes, JR; Rennard, SI; Russ, CI | 1 |
| Barendregt, JJ; Higashi, H | 1 |
| Squire, EN | 1 |
| Caswell, MD; Woods, DJ | 1 |
| Takagi, H; Umemoto, T | 1 |
| Blankfield, RP | 1 |
| Alper, BS | 1 |
| Samuels, L | 1 |
| Kadokura, Y; Kano, M; Kushihashi, Y; Saito, H; Shino, M; Suzaki, H; Suzuki, M; Takiguchi, S; Yamada, Y | 1 |
| Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Plebani, JG; Yu, Q | 1 |
| Barnes, C; Chakraborty-Chatterjee, M; Gamaleddin, I; Goldberg, SR; Khaled, M; Le Foll, B; Lev-Ran, S; Pushparaj, A; Yan, Y | 1 |
| Ashare, RL; McKee, SA | 1 |
| Leung, LK; Patafio, FM; Rosser, WW | 1 |
| Baker, TB; Fiore, MC | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Sved, AF; Weaver, MT | 1 |
| Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
| Cohen, J; Cui, Q; Elston, D; McFarland, N; McIvor, A; Quan, C; Robinson, L; Smaill, F; Smieja, M; Thabane, L; Zeidler, J | 1 |
| Lin, KW | 1 |
| Ansermot, N; Choong, E; Cornuz, J; Dobrinas, M; Eap, CB; Noetzli, M | 1 |
| Lock, K; Murphy, D; Riesco, JA; Wilson, K | 1 |
| Cho, DM; Jung, DU; Jung, SS; Kang, JW; Kelly, DL; Kim, SD; Kong, BG; Lee, JH; Lee, SW; McMahon, RP; Oh, MK; Seo, YS; Shim, JC | 1 |
| Benowitz, NL; Bierut, LJ; Conti, DV; Kaprio, J; King, DP; Lerman, C; Paciga, S; Park, PW; Pickering, E | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| Arteaga, C; Cinciripini, PM; Hughes, J; Kralikova, E; Raupach, T; Rennard, S; Russ, C; St Aubin, LB | 1 |
| Browning, KK; Ferketich, AK; Hall, N; King, M; Otterson, GA; Wewers, ME | 1 |
| Saito, Y; Takami, T | 1 |
| Bhindi, R; Kozor, R | 1 |
| Fidler, J; Kotz, D; West, R | 1 |
| Ashare, RL; Cummings, KM; Gass, JC; Hawk, LW; Lohnes, SF; Mahoney, MC; Rhodes, JD; Schlienz, NJ; Tiffany, ST | 1 |
| Ashton, J; Harrison-Woolrych, M; Maggo, S; Savage, R; Tan, M | 1 |
| Forcen, FE; Martinez, FL; Moya, AM | 1 |
| Lockhart, I; Mardle, T; Merrett, S; Percival, F; Wright, J | 1 |
| Coleman, T; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Heydari, G; Masjedi, MR; Tafti, SF; Talischi, F | 1 |
| Grady, SR; Marks, MJ; O'Neill, HC; Ortiz, NC | 1 |
| Paslin, D | 1 |
| Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN | 1 |
| Eggertson, L | 1 |
| Coleman, CI; Mahmoudi, M; Sobieraj, DM | 1 |
| Beekman, FJ; Booij, J; Crunelle, CL; de Bruin, K; de Wit, TC; Ramakers, RM; van den Brink, W; van der Have, F | 1 |
| Härmark, L; Harrison-Woolrych, M; Maggo, S; Tan, M; van Grootheest, K | 1 |
| Chen, R; Greenstein, PE; Jahan, I; Miller, A; Perlman, SL; Sullivan, KL; Wecker, L; Zesiewicz, TA | 1 |
| Bechara, A; McNutt, A; Tranel, D | 1 |
| Bai, CX; Jin, WT; Pan, J; Wang, XD; Zhang, J | 1 |
| Schuurmans, MM; Zellweger, JP | 1 |
| Childs, E; de Wit, H; King, AC; Roche, DJ | 1 |
| Cicero Guerrero, A; Cristobal Fernández, M; Jiménez Ruiz, CA; Lopez Gonzalez, G; Mayayo Ulibarri, M; Ramos Pinedo, A | 1 |
| Ahluwalia, JS; Benowitz, NL; Berg, CJ; Buchanan, TS; Choi, WS; Cox, LS; Jacob, P; Nazir, N; Nollen, NL; Yturralde, O; Yu, L | 1 |
| Anderson, BJ; Audet, DA; de Dios, MA; Stanton, C; Stein, M | 1 |
| Alvarez-Estrada, M; Brody, AL; Lotfipour, S; Mandelkern, M | 1 |
| Cuesta, G; Lovato, P; Lutz, MA | 2 |
| Azar, MR; Cohen, A; Fox, BS; George, O; Goeders, NE; Koob, GF | 1 |
| Goldstein, AO; Kistler, CE | 1 |
| Cunningham, CS; Javors, MA; McMahon, LR | 1 |
| Fagerström, K; Foulds, J; Russ, C; Yu, CR; Yunis, C | 1 |
| Al Hossaini, AM; Kassem, MG | 1 |
| Gass, JC; Hawk, LW; Mahoney, MC; Tiffany, ST; Wray, JM | 1 |
| Christalla, P; Dewenter, M; El-Armouche, A | 1 |
| Adams, M; Bastiampillai, T; Gupta, A; Nance, M; Nelson, A | 1 |
| Inui, K; Kajiwara, M; Katsura, T; Masuda, S; Terada, T; Watanabe, S | 1 |
| Ashare, RL; Hawk, LW; Mahoney, MC; Rhodes, JD; Schlienz, NJ | 1 |
| Etter, JF; Schneider, NG | 1 |
| Larzelere, MM; Williams, DE | 1 |
| Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH | 1 |
| Bordia, T; Chin, M; Hrachova, M; McIntosh, JM; Quik, M | 1 |
| Gallagher, T; Haseler, CA; Rucktooa, P; Sixma, TK; Smit, AB; van Elk, R | 1 |
| Hilton, JF; Prochaska, JJ | 1 |
| Johnson, MW; McClure, EA; Stitzer, ML; Vandrey, RG | 1 |
| Papke, RL; Stokes, C | 1 |
| Browning, KK; Diaz, P; Ferketich, AK; Koletar, SL; Lu, B; Reynolds, NR; Wewers, ME | 1 |
| Bertrand, D; Billen, B; Brams, M; Smit, AB; Spurny, R; Ulens, C; Valera-Kummer, S; van Elk, R; Voets, T; Yakel, JL | 1 |
| De Letter, EA; Lambert, WE; Piette, MH; Stove, CP | 1 |
| AlSharari, SD; Carroll, FI; Damaj, MI; McIntosh, JM | 1 |
| Bambha, K; Sprague, D | 1 |
| Carter, V; Mishagina, N; Paradis, PE; Raymond, V | 1 |
| Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ | 1 |
| Anthenelli, RM; George, TP; Morris, CD; Thompson, JR; Treadow, J; Williams, JM; Yunis, C | 1 |
| Bradley-Ewing, A; Catley, D; Ellerbeck, E; Goggin, K; Harris, KJ; Liston, R; Malomo, D; Patten, C; Resnicow, K; Richter, K; Williams, K | 1 |
| Dhelaria, RK; Friderici, J; Gupta, E; Khan, C; Rothberg, MB; Wu, K | 1 |
| Iida, H; Iida, M; Iwata, K; Takenaka, M; Tanabe, K | 1 |
| Amato, M; Bates, DW; Haas, JS; Marinacci, L; Orav, EJ; Schiff, GD | 1 |
| Ju, W; Jung, HS; Kim, H; Myung, SK; Oh, SW; Park, CH; Seo, H | 1 |
| Coster, TS; Graham, DJ; Meyer, TE; Moeny, D; Mosholder, AD; Ouellet-Hellstrom, RP; Taylor, LG; Williams, JR; Xie, S | 1 |
| Athanasakis, K; Igoumenidis, M; Karampli, E; Kyriopoulos, J; Sykara, G; Vitsou, E | 1 |
| Akk, G; Esch, C; Herder, P; Laughlin, JR; Li, P; Stitzel, JA; Tammimäki, A | 1 |
| Ebbert, JO; Lockhart, I; Mills, EJ; Puhan, M; Thorlund, K; Wu, P | 1 |
| Duaso, M; Duncan, D | 1 |
| Abrishami, A; Chapman, KR; Chung, F; Friedman, Z; Selby, P; Wong, J; Yang, Y; Zaki, A | 1 |
| Bansal-Travers, M; Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, AJ; Kasza, KA; McNeill, AD | 1 |
| Blendy, JA; Cousins, V; Hussmann, GP; Kellar, KJ; Levin, ED; Lomazzo, E; Perry, DC; Rezvani, AH; Turner, JR; Venkatesh, R; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Garg, PK; Garg, S; Gould, RW; Nader, MA | 1 |
| Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK | 1 |
| Cerimele, JM; Durango, A | 1 |
| Andreas, S; Chenot, JF; Diebold, R; Mann, K; Peachey, S | 1 |
| Jao, NC; Karelitz, JL; Perkins, KA | 1 |
| Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, SJ; Jannes, J; Koblar, SA; Labiszewski, NA; Litt, J; Peters, MJ; Smith, BJ; Veale, AJ | 1 |
| Argo, T; Cantrell, M; Haak, L; Janney, L | 1 |
| Mikkelsen, K; Tønnesen, P | 1 |
| Brown, VL; Cinciripini, PM; Cui, Y; Dani, JA; Engelmann, JM; Karam-Hage, M; Kosten, TR; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Cesario, A; Granone, P; Lococo, F; Petracca-Ciavarella, L; Russo, P | 1 |
| Cowen, PJ; Harmer, CJ; McTavish, SF; Mocking, RJ; Parsons, E; Patrick Pflanz, C; Pringle, A | 1 |
| Rigotti, NA | 2 |
| Carroll, AJ; Hong, LE; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 2 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Abe, TO; Issa, JS; Moura, S; Pereira, AC; Santos, PC | 1 |
| Dautzenberg, B | 1 |
| Hviid, A; Pasternak, B; Svanström, H | 2 |
| Caudill, C; Dumire, W; Lewis, A; Morgan, SK | 1 |
| Baker, AL; Castle, D; Filia, SL; Harris, D; Pirola-Merlo, AJ; Richmond, R | 1 |
| Colivicchi, F; Imperoli, G; Mocini, D; Santini, M; Strano, S; Uguccioni, M | 1 |
| Danto, S; DiBenedetti, DB; Hitsman, B; Hogarth, L; Lee, TC; Niaura, R; Price, LH; Shadel, WG; Teige, JC; Tseng, LJ | 1 |
| Brauer, R; Fahim, RE; Hoogsteder, PH; Kalnik, MW; Kessler, PD; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W | 1 |
| Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP | 1 |
| Harrison-Woolrych, M; Tan, M | 1 |
| Lancaster, T; Stead, LF | 1 |
| Biała, G; Budzyńska, B; Kruk-Słomka, M | 1 |
| Borland, R; Cummings, KM; Fong, GT; Harrison, EL; Hyland, A; Kahler, CW; McKee, SA; Young-Wolff, KC | 1 |
| Camarelles Guillem, F; Clemente Jiménez, L; Dalmau González-Gallarza, R; Díaz-Maroto Muñoz, JL; Lozano Polo, A; Pinet Ogué, MC | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Ahmed, AI; Ali, AN; Burger, DM; Härmark, LV; Kramers, C; Verhoeven, WM | 1 |
| Bujarski, S; Krull, JL; Lunny, K; Miotto, K; Moallem, N; Ray, LA | 1 |
| Arnsten, JH; Bernstein, SL; Nahvi, S; Richter, KP; Wu, B | 1 |
| Busto, UE; Cassels, BK; Gysling, K; Quintanilla, ME; Sotomayor-Zárate, R; Tampier, L | 1 |
| Enger, C; Gately, R; Mo, J; Petronis, KR; Seeger, JD; Younus, M | 1 |
| Aman, M; Anand, R; Arnold, LE | 1 |
| Dixon-McDougall, T; Nowak, C; Pereira, S; Qian, C; Sellings, L; Tyndale, RF; van der Kooy, D; Zhao, B | 1 |
| Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C | 1 |
| Damborsky, JC; DuBois, DW; Fincher, AS; Frye, GD; Winzer-Serhan, UH | 1 |
| Ginsburg, BC; Lamb, RJ | 2 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Brady, KT; George, MS; Gray, KM; Hartwell, KJ; Lematty, T; McRae-Clark, AL | 1 |
| Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D | 1 |
| Porwal, M; Tsoi, DT; Webster, AC | 1 |
| Galaznik, A; Harnett, J; Kirchner, HL; Leader, JB; Liberman, JN; Lichtenfeld, MJ; Mastey, V; Zou, KH | 1 |
| Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D | 1 |
| Aubin, HJ; Berlin, I; Luquiens, A | 1 |
| Brose, LS; Stapleton, JA; West, R | 1 |
| Fatemi, SH; Folsom, TD; Kneeland, RE; Liesch, SB; Thuras, PD; Yousefi, MK | 1 |
| Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Bawagan, J | 1 |
| Cho, B; Park, PW; Wajsbrot, D; Wang, C; Xiao, D | 1 |
| Bölcskei, PL; Davis-Wagner, P; Grundnig, J; Pommer, P | 1 |
| Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS | 1 |
| Kurioka, N | 1 |
| Behm, FM; Rose, JE | 2 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
| Buggy, Y; Cornelius, V; Fogg, C; Kasliwal, R; Layton, D; Shakir, SA | 1 |
| Dal Pan, GJ | 1 |
| Davis, R; Kmetova, A; Kralikova, E; Stepankova, L; West, R; Zvolska, K | 1 |
| Blythe, EE; Dougherty, DA; Lester, HA; Van Arnam, EB | 1 |
| Berg, A; Foulds, J; Franzon, M; Galaznik, A; Hughes, JR; Russ, C; Yu, CR; Zou, KH | 1 |
| Del Nogal Sáez, F; Fuentes Ponte, M; Meyer García-Sipido, E; Sanz Sanz, CL | 1 |
| Cowan, CM; Dezee, KJ; Wink, JS | 1 |
| Antilla, JC; Bickford, PC; Engberg, ME; Hudson, CE; Kang, CW; Lambert, CS; Philpot, RM; Rowell, PP; Wecker, L; Zesiewicz, TA | 1 |
| Dhanji, AR; Hajek, P; McRobbie, H; Smith, KM | 1 |
| Cahill, K; Lancaster, T; Perera, R; Stevens, S | 1 |
| Abella, F; Baena, A; Banque, M; Bullon, R; Carreras, JM; Comino, A; Jimenez-Muro, A; Marqueta, A; Masuet-Aumatell, C; Morchon, S; Nerin, I; Pinet, C; Ramon, JM; Vilarasau, A | 1 |
| Airoldi, A; Bassi, L; Giovannelli, F; Radovanovic, D; Santus, P | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Al-Haj, A; Alawi, M; Arafat, T; Hourani, MK | 1 |
| Brasic, JR; Chamroonrat, W; Dannals, RF; Gao, Y; Gean, EG; Horti, AG; Kim, J; Kuwabara, H; Mathur, A; McCaul, ME; Valentine, H; Wand, G; Willis, W; Wong, DF | 1 |
| Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF | 2 |
| Bacher, I; George, TP; Rabin, RA; Wass, CE; Wing, VC | 1 |
| Rahman, S; Sajja, RK | 1 |
| Brown, J; Kotz, D; West, R | 3 |
| Cowen, PJ; Harmer, CJ; McTavish, SF; Mocking, RJ; Parsons, E; Pflanz, CP; Pringle, A; Schene, AH; Wever, SA | 1 |
| Acuña, M; Bertoglia, MP; Bustamante, P; Cavada, G; Navarrete, S; Peña, P; Suárez, C; Zagolin, M | 1 |
| Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Plebani, JG; Rennert, L | 1 |
| Brose, L; Brown, J; Herbec, A; Raupach, T; West, R | 1 |
| Harrison-Woolrych, M; Paterson, H; Tan, M | 1 |
| Goelz, P; Gupta, T; Jain, R; Jain, V; Jhanjee, S; Mittal, S; Schnoll, RA; Wileyto, EP | 1 |
| Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD | 1 |
| Anderson, MD; Jemec, GB; Zabludovska, K | 1 |
| Eibl, C; Guendisch, D; Mineur, YS; Papke, RL; Peng, C; Picciotto, MR; Stokes, C; Tian, C; Tomassoli, I | 1 |
| Ebbert, JO; Frye, MA; Geske, JR; Lineberry, TW; Patten, CA; Prince, CA | 1 |
| Hajek, P; Hartmann-Boyce, J; Jarvis, M; Lancaster, T; Stead, LF; West, R | 1 |
| Alexander, JC; Bruijnzeel, AW; Igari, M; Ji, Y; Papke, RL; Qi, X | 1 |
| Aubin, HJ; Le Houezec, J | 1 |
| Trivedi, D | 1 |
| Clair, C; Rigotti, NA | 1 |
| Baker, NL; Carpenter, MJ; Gray, KM; McClure, EA; Saladin, ME | 1 |
| Frohlich, J; Graham, A; McNaughton, B; Young, QR | 1 |
| Gibbons, RD; Mann, JJ | 1 |
| Kaminski, BJ; Weerts, EM | 1 |
| Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C | 1 |
| Kaakkola, S; Tuominen, R | 1 |
| Hughes, JR; Messig, MA; Russ, C | 1 |
| Boomershine, V; Haber, SL; Raney, E | 1 |
| Evins, AE; Fullerton, CA; Hoeppner, SS; Roh, S; Schoenfeld, D; Stoeckel, LE | 1 |
| Davies, NM; Gunnell, D; Martin, RM; Metcalfe, C; Thomas, KH; Windmeijer, F | 1 |
| Romigi, A; Vitrani, G | 1 |
| Cappell, K; Galaznik, A; Lenhart, G; Makinson, G; Montejano, L; Zou, KH | 1 |
| Dow, WH; Rungruanghiranya, S; White, JS | 1 |
| Bartholomew, P; Elwell, M; Radi, Z; Vogel, WM | 1 |
| Allan, GM; McCormack, J; Vandermeer, B | 1 |
| Kwong, W; White, CA | 1 |
| Pezzuto, A; Spoto, C; Tonini, G; Vincenzi, B | 1 |
| Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S | 1 |
| Choi, SH; Dubrava, S; Jacobsen, J; Kim, SY; McRae, T; Rollema, H; Schwam, EM | 1 |
| Goutier, W; Kloeze, MB; McCreary, AC | 1 |
| Eren, A; Gecmen, C; Kalayci, A; Karabay, CY; Kirma, C; Kocabay, G | 1 |
| Barrios, M; Cicero, A; Cristóbal, M; Jiménez-Ruiz, CA; Mayayo, M; Peña, S; Perera, L | 1 |
| Lerman, C; Perkins, KA | 1 |
| Carroll, FI; Fivel, PA; Kohut, SJ; Mello, NK | 1 |
| Evins, AE | 1 |
| Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P | 1 |
| Baba, Y; Kurahashi, K; Nagamine, Y; Shimizu, Y | 1 |
| Bobes, J; Diaz-Mesa, E; Elizagarate, E; Galvan, G; Garcia-Alvarez, L; Garcia-Blanco, J; Garcia-Portilla, MP; Saiz, PA; Sarramea, F | 1 |
| Galba, J; Maráková, K; Mikuš, P; Piešťanský, J; Veizerová, L | 2 |
| Bennett, RS; De La Garza, R; Mahoney, JJ; Newton, TF; Thompson-Lake, DG; Verrico, CD | 1 |
| Cobb, NK; Graham, AL; Mays, D | 1 |
| Achtyes, ED; Ayer, D; Cather, C; Evins, AE; Goff, DC; Hoeppner, SS; Pachas, GN; Pratt, SA; Schoenfeld, DA | 1 |
| Allen, SS; Croghan, IT; Ebbert, JO; Hatsukami, DK; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
| Bertrand, D; Hurst, RS; Lee, TC; Rollema, H; Russ, C | 1 |
| Brandon, TH; Correa, JB; Drobes, DJ; Heckman, BW; Marquinez, NS; Roetzheim, RG; Unrod, M | 1 |
| Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP | 1 |
| Gupta, T; Jain, R; Majumder, P | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Daughton, DM; Rennard, SI | 1 |
| Chou, MY; Hsueh, KC; Hsueh, SC; McEwen, A; Pan, LF; Tu, MS; West, R | 1 |
| Hoope, C; Sedgwick, P | 1 |
| Fahrenwald, NL; Kerkvliet, JL | 1 |
| Brusaferro, S; De Bacquer, D; de Velasco, J; Hoes, A; Jennings, C; Jones, J; Kotseva, K; Mead, A; Tonstad, S; Wood, D | 1 |
| Bartlett, SE; Feduccia, AA; Mill, D; Simms, JA; Yi, HY | 1 |
| Buyukuysal, S; Coskun, AS; Goktalay, G; Goktalay, T; Kayir, H; Uslu, G; Uzbay, T; Yorgancioglu, A | 1 |
| Anderson, P; Johnson, M; Lockhart, I | 1 |
| Adachi, T; Inoue, T; Kato, T; Miyagawa, K; Node, K; Taguchi, I; Takeda, H; Toyoda, S; Umeda, A | 1 |
| Anton, RF; Henderson, S; Li, X; Myrick, H; Randall, PK; Schacht, JP | 1 |
| Austin, AJ; Duka, T; Jackson, A; Rusted, J | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Argue, DP; Cousin, MA; Ebbert, JO; Ekker, SC; Klee, EW; Urban, MD; Wiinamaki, AR | 1 |
| Møller, AM; Thomsen, T; Villebro, N | 1 |
| Iwaoka, M; Kugiyama, K; Shimamura, H; Tsuji, T | 1 |
| Ito, H; Nakamichi, N; Nakamura, N; Nozaki, Y; Oze, I; Saka, H; Sakakibara, H; Tachibana, K; Tanaka, H; Taniguchi, C; Tokoro, A | 1 |
| Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA | 2 |
| Kausch, O | 1 |
| Härmark, L; Oosterhuis, I; van Puijenbroek, E | 1 |
| Cantrell, A; Everson-Hock, E; Leaviss, J; Ren, S; Stevens, JW; Stevenson, M; Strong, M; Sullivan, W | 1 |
| Davis, C; Galaznik, A; Joshi, AV; Patel, NC; Suehs, BT; Zou, KH | 1 |
| Aitken, D; Clyde, M; Corran, B; Els, C; Pipe, A; Reid, RD; Tulloch, H | 1 |
| Arnsten, JH; Nahvi, S; Ning, Y; Richter, KP; Segal, KS | 1 |
| Andrea, D; Braida, D; Cannazza, G; Clementi, F; Fasoli, F; Gotti, C; Manfredi, I; Papke, RL; Ponzoni, L; Pucci, L; Sala, M; Stokes, C | 1 |
| Sedgwick, P | 3 |
| Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P | 1 |
| Hoogsteder, PH; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W | 1 |
| Mendelsohn, CP; Richmond, RL; Zwar, NA | 1 |
| Erken, G; Erken, HA; Genç, O; Koç, ER; Korkut, O; Simşek, H; Yavuz, O | 1 |
| Rausch, R | 1 |
| Gonzales, D; Hajek, P; McRae, TD; Nackaerts, K; Pliamm, L; Treadow, J; Tseng, LJ | 1 |
| Arnsten, JH; Litwin, AH; Nahvi, S; Segal, KS | 1 |
| De La Garza, R; Kalechstein, AD; Mahoney, JJ; Verrico, CD | 1 |
| Hawk, LW; Mahoney, MC; O'Connor, RJ; Schlienz, NJ; Tiffany, ST | 1 |
| Anderson, BJ; Caviness, CM; de Dios, MA; Stein, MD | 1 |
| Caro Gutiérrez, D; Feltes Ochoa, RA; Gómez de la Fuente, E; López Estebaranz, JL; Salamanca Santamaría, FJ | 1 |
| Kmeťová, A; Králíková, E; Zvolská, K | 1 |
| Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN | 1 |
| Brar, JS; Chengappa, KN; George, TP; Hetrick, ML; Levine, MD; Perkins, KA; Schlicht, PJ; Turkin, SR | 1 |
| Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, S; Hnin, KM; Jannes, J; Koblar, SA; Litt, J; Peters, MJ; Singh, K; Smith, BJ; Veale, AJ | 1 |
| By, K; Graham, DJ; Kelman, JA; Kornegay, C; Levenson, M; MaCurdy, TE; McKean, S; Mosholder, A; Racoosin, JA; Worrall, C; Young, J | 1 |
| Freedman, R; Indersmitten, T; Leonard, S; Lester, HA; Wang, Y; Xiao, C | 1 |
| Baker, NL; Carpenter, MJ; Froeliger, BE; Gipson, CD; Gray, KM; Kalivas, PW; McClure, EA; Roper, AP | 1 |
| Castillo-Fernández, E; Lara-Fernández, M; López-Quirantes, EM; López-Torrecillas, F; Nieto-Ruiz, A; Velasco-Ortuño, S | 1 |
| Goldberg, JF | 1 |
| Erwin, BL; Slaton, RM | 1 |
| Bujarski, S; Ray, LA | 1 |
| Booth, R; Kim, H | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, SM; Javitz, HS; Kim, RB; Krasnow, R; Kwok, PY; McClure, JB; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Faessel, HM; Gastonguay, MR; Lee, TC; Niaura, R; Ravva, P | 1 |
| Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Schassburger, RL; Sved, AF; Weaver, MT | 1 |
| Fisher, DC; Fletcher, PJ; Guy, EG; Higgins, GA | 1 |
| Ditre, JW; Farris, SG; Leventhal, AM; Schmidt, NB; Zvolensky, MJ | 1 |
| Britton, J; Huang, Y; Lewis, S | 1 |
| Adams, S; Attwood, AS; McClernon, FJ; Munafò, MR; Williams, T | 1 |
| Baena, A; Masuet-Aumatell, C; Morchon, S; Ramon, JM | 1 |
| Steurer, J | 1 |
| Abe, S; Imaizumi, S; Kawachi, E; Matsuo, Y; Miura, S; Noda, K; Saku, K; Shimizu, T; Suematsu, Y; Takata, K; Tsukahara, H; Uehara, Y; Yahiro, E; Zhang, B | 1 |
| Barra, NG; De Long, NE; Hardy, DB; Holloway, AC | 1 |
| Barkema, HW; Clement, F; Coward, S; Ghosh, S; Heitman, SJ; Kaplan, GG; Leung, YP; Negron, M; Panaccione, R; Seow, C | 1 |
| Hogarth, L; Panlilio, LV; Shoaib, M | 1 |
| Preskorn, SH | 1 |
| Caduff-Janosa, P; Savage, RL; Zekarias, A | 1 |
| Arbab-Zadeh, A; Garg, J; Krishnamoorthy, P; Lavie, CJ; Lichstein, E; Sharma, A; Sochor, O; Thakar, S | 1 |
| Ebert, S; Tetrault, JM | 1 |
| Kanaoka, Y; Kataoka, Y; Koga, M; Kubo, N; Ohishi, K; Ohkido, Y; Sugiyama, K; Yamauchi, A | 1 |
| Hooten, WM; Warner, DO | 1 |
| Ballbè, M; Cabezas, C; Fernández, E; Gual, A; Martínez, C; Riccobene, A; Saltó, E; Valverde, A | 1 |
| Arias, HR; Feuerbach, D; Jozwiak, K; Kaczor, AA; Poso, A; Targowska-Duda, K | 1 |
| Becker, C; Bencherif, M; Kucinski, A; Lippiello, P; Stachowiak, EK; Stachowiak, MK; Wersinger, S | 1 |
| Cornwall, D; Dhanji, AR; Hajek, P; McRobbie, H; Myers Smith, K; Phillips, A | 1 |
| Gubner, NR; McKinnon, CS; Phillips, TJ | 1 |
| Chan, S; Cheng, K; He, Y; Jiang, B; Lam, T; Liu, Q; Wu, L; Zhang, L; Zhou, C; Zuo, F | 1 |
| Andreas, S; Reinhardt, C | 1 |
| Dutro, MP; Ebbert, JO; Hughes, JR; McRae, TD; Park, PW; Rennard, SI; Russ, C; Treadow, J; West, RJ; Yu, CR | 1 |
| Cameron, P; Crooks, PA; Dwoskin, LP; Holt, JC; Jordan, PM; Kewin, K; Klapczynski, M; Lysakowski, A; McIntosh, JM | 1 |
| Baker, NL; Carpenter, MJ; Gray, KM; Hartwell, KJ; McClure, EA; Ramakrishnan, V; Saladin, ME | 1 |
| Borland, R; Brady, K; Carpenter, MJ; Cummings, KM; Fong, GT; Hartwell, K; Hyland, A; Kasza, KA; McKee, SA; Smith, PH | 1 |
| Gunnell, D; Higgins, JP; Knipe, DW; Martin, RM; Thomas, KH | 1 |
| Björnsson, ES; Mogensen, H | 1 |
| Nau, JY | 2 |
| Higuchi, S; Kimura, M; Maesato, H; Matsushita, S; Mizukami, T; Nakayama, H; Sakuma, H; Takimura, T; Yokoyama, A; Yoneda, J; Yoshimura, A | 1 |
| Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F | 1 |
| Borland, R; Briggs, VL; Couzos, S; Panaretto, KS; Stevens, M; Thomas, DP; van der Sterren, AE | 1 |
| Fazel, S; Gumpert, CH; Lichtenstein, P; Molero, Y; Zetterqvist, J | 1 |
| Furberg, RD; Krebs, P; Pham, H; Shelley, D; Sherman, SE; Tseng, TY; Wolfe, H; Wong, S | 1 |
| Barras, D | 1 |
| Burkholder, GA; Clark, CB; Cropsey, KL; Jardin, BF; Raper, JL; Saag, MS | 1 |
| He, Y; Sun, S; Wu, L; Zeng, J | 1 |
| Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö | 1 |
| Azuma, J; Fujio, Y; Hirohashi, K; Iguchi, T; Kobayashi, M; Maeda, M; Morimura, M; Norioka, N; Shimada, K; Shuto, T; Takemoto, Y; Yoshiyama, M | 1 |
| Koilpillai, P; Lancaster, T; Stead, LF | 1 |
| Ebbert, JO; Elrashidi, MY; Stead, LF | 1 |
| Primack, BA | 1 |
| Croghan, E; Kiparoglou, V; Robinson, H; van Woerden, HC; Walker, NJ; Yang, Y | 1 |
| Kress, CM; Obi, NU; Prochazka, AV | 1 |
| Brath, H; Fasching, P; Kaser, S; Tatschl, C | 1 |
| George, TP; Kozak, K | 1 |
| Ashare, RL; Bauer, AM; Flitter, A; Gross, R; Hitsman, B; Hosie Quinn, M; Leone, FT; Lubitz, SF; Schnoll, R | 1 |
| Benipal, S; Bilimoria, K; Budhram, DR; Persaud, N; Wang, R; Woods, H | 1 |
| Colder, CR; Cooper, RK; Gass, JC; Hawk, LW; Lawson, SC; Mahoney, MC; Tiffany, ST; Tonkin, SS | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| Benowitz, N; Clarke, A; Jacobs, C; Nides, M; Rigotti, NA | 1 |
| Anthenelli, RM; Aubin, LS; Beard, E; Benowitz, NL; Evins, AE; Jackson, SE; Krishen, A; Lawrence, D; McRae, T; Russ, C; West, R | 1 |
| Boezen, HM; Bos, JH; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B | 1 |
| Boezen, HM; Bos, JHJ; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B | 1 |
| Goldman, RD; Yan, T | 1 |
| Hussain, S; Le Foll, B; Mansoursadeghi-Gilan, T; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H | 1 |
| Mills, J | 1 |
| Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S | 1 |
| Cinciripini, P; Colder, C; George, TP; Hawk, LW; Mahoney, MC; Schnoll, R; Swan, GE; Tonkin, SS; Tyndale, RF | 1 |
| Alamo, A; Caci, G; Campagna, D; Caponnetto, P; Cibella, F; Di Mauro, M; Franek, E; Frittitta, L; Krysinski, A; Maglia, M; Polosa, R; Russo, C; Walicka, M | 1 |
| Humair, JP; Papachristou, C | 1 |
| Chang, CT; Choo, SJ; Harun, SN; Latif, MFA; Sanusi, NA; Tangiisuran, B | 1 |
| Kang, DW; Lee, EK; Park, SK | 1 |
| Ashare, RL; Brandon, TH; Colder, CR; Hawk, LW; Mahoney, MC; Tiffany, ST; Tyndale, RF; Wray, JM | 1 |
| Barrett, ST; Bevins, RA; Dwoskin, LP; Huynh, YW; Thompson, BM; Tracy, ME | 1 |
| Correia, C; Correia, T; Fernandes, S; Filipe, P; Soares-de-Almeida, L | 1 |
| Bastian, J; Bauer, AM; Fox, EN; Gollan, JK; Hitsman, B; Hole, A; Huffman, MD; Khan, SS; Leone, FT; Lubitz, SF; Mohr, DC; Niaura, R; Papandonatos, GD; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP | 1 |
| Eisenberg, MJ; Moiz, A | 1 |
| Ahluwalia, JS; Busa, B; Campagna, D; Caponnetto, P; Longo, CF; Maglia, M; Polosa, R; Riela, PM; Russell, C | 1 |
| Budzyńska, B; Chałas, R; Maciąg, M; Rahnama-Hezavah, M; Stachurski, P; Świątkowska, A; Świątkowski, W; Tylżanowski, P | 1 |
159 review(s) available for quinoxalines and varenicline
| Article | Year |
|---|---|
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
Topics: Benzazepines; Brain; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2006 |
Varenicline: a review of its use as an aid to smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2006 |
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2006 |
[New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
Topics: Animals; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Oral varenicline for smoking cessation.
Topics: Administration, Oral; Animals; Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2007 |
Non-nicotinic therapies for smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2007 |
Varenicline for smoking cessation.
Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Varenicline: new treatment with efficacy in smoking cessation.
Topics: Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline | 2007 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Hospitalization; Humans; Internet; Physician's Role; Practice Patterns, Physicians'; Quinoxalines; Receptors, Nicotinic; Risk Reduction Behavior; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
[Varenicline--a new drug for smoking cessation].
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
[Varenicline (Champix)].
Topics: Adult; Benzazepines; Contraindications; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2007 |
Smoking cessation: lessons learned from clinical trial evidence.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2007 |
Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
Topics: Animals; Benzazepines; Drug Design; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Varenicline: the newest agent for smoking cessation.
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Drug Interactions; Humans; Nicotine; Quinoxalines; Receptors, Cholinergic; Smoking Cessation; Varenicline | 2007 |
Varenicline: progress in smoking cessation treatment.
Topics: Animals; Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline | 2007 |
Optimizing on smoke free legislation making the most of the opportunity.
Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline | 2007 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health | 2007 |
Smoking cessation: an overview of treatment options with a focus on varenicline.
Topics: Benzazepines; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2007 |
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Treatment of tobacco dependence: integrating recent progress into practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Health Behavior; Health Policy; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Breaking the ties of nicotine dependence.
Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
Smoking cessation and lung cancer: oncology nurses can make a difference.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People | 2008 |
Efficacy and safety of varenicline for smoking cessation.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
[Varenicline--a new chance for smokers?].
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
Smoking cessation in pregnancy: why, how, and what next...
Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
[The ABC of smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
Varenicline and its role in smoking cessation.
Topics: Benzazepines; Humans; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Which drug to be used in smoking cessation?
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Clinical inquiries. What are the most effective ways you can help patients stop smoking?
Topics: Benzazepines; Counseling; Family Practice; Health Promotion; Humans; Medical History Taking; Office Visits; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2008 |
Smoking cessation therapy with varenicline.
Topics: Benzazepines; Humans; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
The relevance and treatment of cue-induced cravings in tobacco dependence.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Drugs for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
Topics: Benzazepines; Combined Modality Therapy; Complementary Therapies; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Psychotherapy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Clinical Trials as Topic; Dopamine; Humans; Nicotinic Agonists; Quinolizines; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Topics: Animals; Behavior, Addictive; Benzazepines; Bupropion; Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Quinoxalines; Smoking; Tobacco Use Disorder; Varenicline | 2009 |
[Modern medical support for smoking cessation].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
[Not smoking, essential for healthy lungs].
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline | 2008 |
Smoking cessation in pregnancy.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Update in new medications for primary care.
Topics: Animals; Antihypertensive Agents; Benzazepines; Drugs, Investigational; Humans; Primary Health Care; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Tobacco smoking cessation management: integrating varenicline in current practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Pharmacotherapy for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain | 2009 |
Smoking in pregnancy and lactation: a review of risks and cessation strategies.
Topics: Adult; Alkaloids; Antidepressive Agents; Azocines; Benzazepines; Breast Feeding; Bromocriptine; Cognitive Behavioral Therapy; Female; Humans; Lactation; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinolizines; Quinoxalines; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Vaccines; Varenicline; Young Adult | 2009 |
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Emerging drugs for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Varenicline: a first-line treatment option for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Update on smoking cessation therapies.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline | 2009 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Pharmacogenetics of smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
A longer course of varenicline therapy improves smoking cessation rates.
Topics: Benzazepines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Patient Compliance; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Risk Assessment; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2008 |
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline | 2009 |
Varenicline: a novel pharmacotherapy for smoking cessation.
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Humans; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Varenicline in the management of smoking cessation: a single technology appraisal.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Nicotinic Agonists; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Nicotine dependence and smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
Topics: Alcohol Drinking; Animals; Behavior, Addictive; Benzazepines; Brain; Dopamine; Drug Partial Agonism; Humans; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Secondary Prevention; Smoking Cessation; Substance-Related Disorders; Varenicline | 2010 |
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Topics: Benzazepines; Cardiovascular Diseases; Drug Labeling; Humans; Mental Disorders; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Current approaches to pharmacotherapy for smoking cessation.
Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline | 2010 |
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Varenicline use in patients with mental illness: an update of the evidence.
Topics: Benzazepines; Evidence-Based Medicine; Humans; Limbic System; Mental Disorders; Mood Disorders; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Suicide; Treatment Outcome; Varenicline | 2010 |
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Benzazepines; Brain; Humans; Mecamylamine; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2010 |
Smoking cessation intervention: an evidence-based approach.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2010 |
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Sleep Wake Disorders; Smoking Cessation; Varenicline | 2010 |
Improving the effectiveness of tobacco use cessation (TUC).
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Chewing Gum; Counseling; Dental Offices; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Referral and Consultation; Smoking; Tobacco Use Cessation; Varenicline | 2010 |
[Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)].
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Corpus Striatum; Dopamine; Humans; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Varenicline in smoking cessation.
Topics: Animals; Benzazepines; Drug Administration Schedule; Drug Approval; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2010 |
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline | 2010 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries.
Topics: Adult; Aged; Asia; Asian People; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nicotinic Agonists; Placebos; Population; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation.
Topics: Benzazepines; Cost-Benefit Analysis; Health Care Costs; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
[Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization].
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Tobacco Use Disorder; Varenicline | 2011 |
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.
Topics: Acetylcholine; Animals; Antidepressive Agents; Benzazepines; Depressive Disorder; Drug Partial Agonism; Humans; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Cholinergic; Self Medication; Signal Transduction; Suicidal Ideation; Tobacco Use Disorder; Varenicline | 2010 |
A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities.
Topics: Benzazepines; Cost-Benefit Analysis; Humans; Morbidity; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline | 2011 |
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2010 |
Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Topics: Benzazepines; Cost-Benefit Analysis; Evidence-Based Medicine; Health Promotion; Humans; Nicotinic Agonists; Piperidines; Public Health; Pyrazoles; Qualitative Research; Quinoxalines; Rimonabant; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Marketing; State Medicine; Treatment Failure; United Kingdom; Varenicline | 2010 |
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Benzazepines; Biological Availability; Drug Interactions; Half-Life; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline; Young Adult | 2010 |
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2010 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2011 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2011 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
Pharmacotherapy for smoking cessation: present and future.
Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2011 |
Varenicline for tobacco dependence: panacea or plight?
Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2011 |
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Varenicline | 2011 |
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis.
Topics: Benzazepines; Double-Blind Method; Gastrointestinal Diseases; Humans; Maintenance Chemotherapy; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2011 |
Clinical practice. Treating smokers in the health care setting.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2011 |
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Humans; Markov Chains; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline | 2012 |
[Smoking cessation in medical practice--new possibilities?].
Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Varenicline.
Topics: Animals; Benzazepines; Chromatography; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Spectrum Analysis; Varenicline; X-Ray Diffraction | 2012 |
[Effectiveness and safety of varenicline for smoking cessation].
Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2012 |
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.
Topics: Adult; Benzazepines; Cardiovascular Diseases; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Epidemiologic Methods; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
Topics: Benzazepines; Bupropion; Databases, Bibliographic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Health impact of smoking and smoking cessation strategies: current evidence.
Topics: Benzazepines; Bupropion; Cause of Death; Counseling; Evidence-Based Medicine; Humans; Nicotinic Agonists; Nurse's Role; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Tobacco Use Cessation Devices; United Kingdom; Varenicline | 2012 |
Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
Topics: Adverse Drug Reaction Reporting Systems; Attention; Benzazepines; Cognition Disorders; Disease Progression; Dose-Response Relationship, Drug; Humans; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Risk Factors; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2012 |
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Neuropsychiatric adverse events of varenicline: a systematic review of published reports.
Topics: Adult; Aged; Benzazepines; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Smoking Prevention; Time Factors; Varenicline; Young Adult | 2013 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
Topics: Adolescent; Benzazepines; Bupropion; Counseling; Drug Design; Female; Humans; Molecular Sequence Data; Pregnancy; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
[Current approaches to smoking cessation].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cooperative Behavior; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Germany; Health Priorities; Health Surveys; Humans; Interdisciplinary Communication; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2013 |
[On oral medications, especially varenicline].
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Varenicline and evaluated outcomes in smoking cessation programmes.
Topics: Benzazepines; Clinical Trials as Topic; Humans; Lung; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Medication Adherence; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Benzazepines; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2013 |
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Cochrane review summary: Pharmacological interventions for promoting smoking cessation during pregnancy.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Birth Weight; Bupropion; Female; Humans; Infant, Newborn; Medication Adherence; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Managing tobacco use: the neglected cardiovascular disease risk factor.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Counseling; Female; Health Promotion; Humans; Male; Nicotinic Agonists; Physician's Role; Quinoxalines; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
Topics: Alzheimer Disease; Ataxia; Benzazepines; Cognitive Dysfunction; Epilepsy, Frontal Lobe; Humans; Mutation; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinoxalines; Receptors, Nicotinic; Tobacco Use Cessation Devices; Varenicline | 2013 |
Safety of varenicline in patients with cardiovascular disease.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2014 |
Improvement of restless legs syndrome by varenicline as antismoking treatment.
Topics: Aged, 80 and over; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Nicotinic Agonists; Patient Satisfaction; Quinoxalines; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome; Varenicline | 2013 |
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
Topics: Animals; Benzazepines; Carcinogenicity Tests; Disease Models, Animal; Humans; Hydromorphone; Lipoma; Mutagenicity Tests; Neoplasms; Phentolamine; Piperidines; Pyrimidines; Pyrroles; Quinoxalines; Rats; Risk Assessment; Varenicline | 2013 |
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Cross-Over Studies; Drug Evaluation, Preclinical; Feasibility Studies; Humans; Quinoxalines; Research Design; Smoking Cessation; Validation Studies as Topic; Varenicline | 2014 |
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
Nicotinic receptor antagonists as treatments for nicotine abuse.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Humans; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Smoking; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Pharmacological intervention of nicotine dependence.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Interventions for preoperative smoking cessation.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Postoperative Complications; Preoperative Care; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Topics: Adult; Aged; Alkaloids; Azocines; Benzazepines; Cost-Benefit Analysis; Humans; Middle Aged; Nicotinic Agonists; Quality-Adjusted Life Years; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; State Medicine; United Kingdom; Varenicline | 2014 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; School Health Services; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Varenicline in the treatment of alcohol use disorders.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline | 2014 |
Is it safe to use smoking cessation therapeutics during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Female; Humans; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2014 |
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Topics: Benzazepines; Bupropion; Chest Pain; Dose-Response Relationship, Drug; Humans; Hypertension; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Seizures; Smoking Cessation; Smoking Prevention; Tachycardia; Varenicline | 2015 |
[Smoking cessation--what's new?].
Topics: Benzazepines; Combined Modality Therapy; Electronic Nicotine Delivery Systems; Humans; Motivational Interviewing; Nicotinic Agonists; Patient Compliance; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Smoking Cessation; Varenicline | 2015 |
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.
Topics: Aggression; Benzazepines; Depression; Humans; Mental Disorders; Quinoxalines; Risk Factors; Sleep Wake Disorders; Suicide; Suicide, Attempted; Tobacco Use Cessation Devices; Varenicline | 2015 |
Interventions to increase adherence to medications for tobacco dependence.
Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2015 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2015 |
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2020 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Varenicline-induced drug eruption: case and review of the literature.
Topics: Acute Generalized Exanthematous Pustulosis; Benzazepines; Drug-Related Side Effects and Adverse Reactions; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2023 |
180 trial(s) available for quinoxalines and varenicline
| Article | Year |
|---|---|
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.
Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Factor Analysis, Statistical; Humans; Middle Aged; Nicotinic Agonists; Psychometrics; Quinoxalines; Reinforcement, Psychology; Reproducibility of Results; Reward; Sensation; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2007 |
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
Topics: Administration, Oral; Adolescent; Adult; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Health; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Varenicline | 2006 |
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.
Topics: Administration, Oral; Aged; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting | 2006 |
A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinoxalines; Smoking Cessation; Smoking Prevention; Time; Time Factors; Treatment Outcome; Varenicline | 2007 |
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
Topics: Absenteeism; Benzazepines; Bupropion; Cost Savings; Cost-Benefit Analysis; Decision Trees; Employer Health Costs; Health Benefit Plans, Employee; Humans; Maintenance; Nicotinic Agonists; Program Evaluation; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Time Factors; Varenicline | 2007 |
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Topics: Adult; Aged; Asian People; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Taiwan; Treatment Outcome; Varenicline | 2007 |
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
Topics: Adult; Aged; Asian People; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
Topics: Adolescent; Adult; Anticoagulants; Benzazepines; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Hepatocytes; Humans; International Normalized Ratio; Male; Microsomes, Liver; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Varenicline; Warfarin | 2007 |
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.
Topics: Adult; Benzazepines; Chromatography, High Pressure Liquid; Cimetidine; Embryo, Mammalian; Enzyme Inhibitors; Female; Humans; Kidney; Male; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tandem Mass Spectrometry; Varenicline | 2008 |
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2008 |
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
Topics: Adult; Amphetamine; Benzazepines; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Nicotinic Agonists; Odds Ratio; Quinoxalines; Reproducibility of Results; Smoking; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Varenicline | 2008 |
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.
Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Caco-2 Cells; Digoxin; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Varenicline improves mood and cognition during smoking abstinence.
Topics: Adult; Affect; Attention; Benzazepines; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Nicotinic Agonists; Quinoxalines; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Internet; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Sex Factors; Smoking Cessation; Smoking Prevention; Telephone; Varenicline | 2009 |
Varenicline for smoking cessation: a placebo-controlled, randomized study.
Topics: Adolescent; Adult; Aged; Benzazepines; China; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Singapore; Smoking Cessation; Thailand; Treatment Outcome; Varenicline; Young Adult | 2009 |
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline.
Topics: Adult; Affect; Benzazepines; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adolescent; Area Under Curve; Benzazepines; Body Weight; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Treatment Outcome; Varenicline | 2009 |
Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Topics: Adult; Aged; Benzazepines; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult | 2009 |
Varenicline reduces alcohol self-administration in heavy-drinking smokers.
Topics: Adult; Alcoholism; Benzazepines; Central Nervous System Depressants; Double-Blind Method; Ethanol; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline; Young Adult | 2009 |
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzazepines; Carbon Dioxide; Cognition; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking; Time Factors; Varenicline | 2009 |
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
Topics: Adult; Aged; Benzazepines; Combined Modality Therapy; Counseling; Female; Humans; Japan; Male; Markov Chains; Middle Aged; Models, Economic; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2009 |
The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers.
Topics: Adolescent; Adult; Area Under Curve; Asian People; Benzazepines; China; Drug Administration Schedule; Female; Half-Life; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Young Adult | 2009 |
Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation.
Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2009 |
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
Topics: Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Varenicline | 2009 |
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Working memory deficits predict short-term smoking resumption following brief abstinence.
Topics: Adolescent; Adult; Attention; Benzazepines; Female; Humans; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Predictive Value of Tests; Psychomotor Performance; Quinoxalines; Recurrence; Regression Analysis; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Topics: Adult; Appetite Depressants; Benzazepines; Cyclobutanes; Drug Therapy, Combination; Female; Humans; Nicotinic Agonists; Patient Dropouts; Pilot Projects; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline; Weight Gain; Young Adult | 2009 |
Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.
Topics: Acoustic Stimulation; Analysis of Variance; Benzazepines; Double-Blind Method; Evoked Potentials, Auditory; Humans; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reaction Time; Schizophrenia; Sensory Gating; Statistics, Nonparametric; Varenicline | 2010 |
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
Topics: Aged; Benzazepines; Cardiovascular Diseases; Directive Counseling; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Survival Rate; Treatment Outcome; Varenicline | 2010 |
Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials.
Topics: Adult; Alcohol Drinking; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation.
Topics: Adolescent; Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Models, Statistical; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2010 |
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
Topics: Administration, Cutaneous; Adult; Benzazepines; Emotions; Endpoint Determination; Female; Humans; Incidence; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2010 |
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Topics: Adolescent; Adult; Aged; Benzazepines; Brain; Cerebral Cortex; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Oxygen; Psychomotor Performance; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline; Young Adult | 2010 |
Smoking outcome by psychiatric history after behavioral and varenicline treatment.
Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Directive Counseling; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.
Topics: Adult; Animals; Benzazepines; Cross-Over Studies; Evoked Potentials; Female; Humans; Male; Mice; Mice, Inbred C57BL; Nicotine; Placebo Effect; Quinoxalines; Smoking; Varenicline; Young Adult | 2010 |
Behavioral counseling and varenicline treatment for smoking cessation.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Internet; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking Cessation; Telephone; Varenicline; Washington | 2010 |
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Humans; Male; Medication Adherence; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers.
Topics: Administration, Oral; Aged; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Male; Nicotinic Agonists; Placebos; Quinoxalines; Single-Blind Method; Varenicline | 2011 |
Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
Topics: Administration, Cutaneous; Adult; Benzazepines; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Drug Evaluation, Preclinical; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Reproducibility of Results; Research Design; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2010 |
Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers.
Topics: Adult; Benzazepines; Cohort Studies; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Half-Life; Humans; Japan; Male; Nicotinic Agonists; Placebos; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Varenicline; Young Adult | 2011 |
A pilot study to assess smokeless tobacco use reduction with varenicline.
Topics: Adult; Behavior; Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco, Smokeless; Varenicline | 2010 |
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Topics: Aged; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; France; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Respiratory Function Tests; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Spirometry; Treatment Outcome; United States; Varenicline | 2011 |
Changes in health-related quality of life with smoking cessation treatment.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quality of Life; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
Topics: Adult; Benzazepines; Cotinine; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Recurrence; Saliva; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Varenicline | 2010 |
Effects of varenicline on smoking cue–triggered neural and craving responses.
Topics: Adult; Basal Ganglia; Benzazepines; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
A preliminary investigation of varenicline for heavy drinking smokers.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2011 |
Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
Topics: Adult; Aged; Belgium; Benzazepines; Europe; Female; Greece; Humans; Hungary; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Observation; Quinoxalines; Slovenia; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2011 |
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.
Topics: Benzazepines; Counseling; Electronic Mail; Female; Humans; Internet; Male; Middle Aged; Multivariate Analysis; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Telecommunications; Telephone; Treatment Outcome; Varenicline | 2011 |
Adherence to varenicline in the COMPASS smoking cessation intervention trial.
Topics: Benzazepines; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Self Report; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2011 |
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking Cessation; Treatment Outcome; Varenicline | 2011 |
Clinical shorts.
Topics: Adolescent; Age Factors; Benzazepines; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Lymph Nodes; Male; Quinoxalines; Risk Assessment; Sentinel Lymph Node Biopsy; Smoking Cessation; Survival Rate; Treatment Outcome; Varenicline | 2011 |
A pilot clinical trial of varenicline for smoking cessation in black smokers.
Topics: Adult; Behavior Therapy; Benzazepines; Black or African American; Combined Modality Therapy; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline | 2011 |
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Male; Midwestern United States; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult | 2011 |
Brain activity and emotional processing in smokers treated with varenicline.
Topics: Adolescent; Adult; Affect; Aged; Amygdala; Analysis of Variance; Benzazepines; Brain; Cross-Over Studies; Double-Blind Method; Emotions; Facial Expression; Female; Functional Neuroimaging; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Photic Stimulation; Placebos; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.
Topics: Aged; Benzazepines; Counseling; Efficiency, Organizational; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Massachusetts; Middle Aged; Nicotinic Agonists; Oncology Service, Hospital; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Thoracic Surgery; Treatment Outcome; Varenicline | 2011 |
Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Topics: Adult; Benzazepines; Biomarkers; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; London; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline | 2011 |
Varenicline effects on craving, cue reactivity, and smoking reward.
Topics: Adult; Benzazepines; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Reward; Smoking; Time Factors; Varenicline | 2011 |
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
Topics: Benzazepines; Bupropion; Counseling; Cultural Characteristics; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Kansas; Nicotinic Agonists; Oklahoma; Patient Education as Topic; Quinoxalines; Research Design; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.
Topics: Benzazepines; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2012 |
Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
Topics: Benzazepines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinoxalines; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2011 |
Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Africa; Aged; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Latin America; Male; Middle Aged; Middle East; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline; Young Adult | 2011 |
Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial.
Topics: Adult; Benzazepines; Directive Counseling; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Motivation; Nebraska; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Prevention; Tobacco Use Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vermont | 2011 |
The effect of varenicline on heart rate variability in healthy smokers and nonsmokers.
Topics: Adult; Arrhythmias, Cardiac; Benzazepines; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Nicotinic Agonists; Placebos; Quinoxalines; Smoking; Varenicline; Young Adult | 2011 |
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.
Topics: Adult; Benzazepines; Female; Health Behavior; Humans; Male; Middle Aged; Minority Groups; Nicotinic Agonists; Patient Selection; Quinoxalines; Racial Groups; Research Design; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Varenicline | 2011 |
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
Topics: Adolescent; Benzazepines; Bupropion; Double-Blind Method; Female; Humans; Male; Nausea; Pilot Projects; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2012 |
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
Topics: Adult; Attention; Benzazepines; Biomarkers; Cognition; Double-Blind Method; Eye Movements; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Smoking; Varenicline | 2011 |
Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
Topics: Adult; Aged; Behavior Therapy; Benzazepines; Counseling; Double-Blind Method; Feasibility Studies; Female; Hospitalization; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Philippines; Prevalence; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Varenicline | 2011 |
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy.
Topics: Belgium; Benzazepines; Cardiovascular Diseases; Cost-Benefit Analysis; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Portugal; Prevalence; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Spain; Treatment Outcome; Varenicline | 2012 |
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
Topics: Adult; Benzazepines; Cocaine-Related Disorders; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline | 2012 |
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Topics: Adult; Benzazepines; Bupropion; Cognition; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2012 |
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
Topics: Adult; Affect; Benzazepines; Cotinine; Dreams; Female; Follow-Up Studies; HIV Seropositivity; Humans; Indicators and Reagents; Male; Middle Aged; Nausea; Nicotinic Agonists; Ontario; Pilot Projects; Prevalence; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Benzazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
Topics: Adult; Aged; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacogenetics; Quinoxalines; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates.
Topics: Adult; Benzazepines; Drug Administration Schedule; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
Topics: Benzazepines; Early Detection of Cancer; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tomography, X-Ray Computed; Varenicline | 2012 |
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
Topics: Behavior, Addictive; Benzazepines; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Characteristics; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Varenicline | 2012 |
Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran.
Topics: Adult; Benzazepines; Female; Follow-Up Studies; Humans; Iran; Male; Nicotinic Agonists; Prevalence; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Topics: Adult; Affect; Aged; Benzazepines; Double-Blind Method; Female; Gait; Humans; Machado-Joseph Disease; Male; Middle Aged; Motor Activity; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline | 2012 |
[The evaluation of strengthened psychological and behavioral intervention in smoking cessation clinics].
Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Psychotherapy; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2011 |
Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.
Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Recurrence; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Linear Models; Male; Middle Aged; Nicotinic Agonists; Placebo Effect; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline | 2012 |
Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.
Topics: Adult; Benzazepines; Computers, Handheld; Cues; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2012 |
The effects of varenicline on attention and inhibitory control among treatment-seeking smokers.
Topics: Adolescent; Adult; Aged; Attention; Benzazepines; Cognition; Drug Administration Schedule; Humans; Inhibition, Psychological; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2012 |
Varenicline decreases alcohol consumption in heavy-drinking smokers.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2012 |
Effects of varenicline on abstinence and smoking reward following a programmed lapse.
Topics: Adult; Benzazepines; Cotinine; Female; Humans; Male; Middle Aged; Patient Compliance; Prospective Studies; Quinoxalines; Reward; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2013 |
Safety of varenicline among smokers enrolled in the lung HIV study.
Topics: Adult; Benzazepines; Female; HIV Infections; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2013 |
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult | 2012 |
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Benzazepines; Canada; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking Cessation; United States; Varenicline | 2012 |
Motivational Interviewing for encouraging quit attempts among unmotivated smokers: study protocol of a randomized, controlled, efficacy trial.
Topics: Adult; Benzazepines; Health Education; Humans; Motivation; Motivational Interviewing; Nicotinic Antagonists; Patient Selection; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2012 |
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cotinine; Counseling; Double-Blind Method; Female; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Recurrence; Sample Size; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2012 |
Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Comorbidity; Depression; Female; Germany; Humans; Hypertension; Incidence; Lung Diseases, Obstructive; Male; Middle Aged; Nicotinic Agonists; Observation; Primary Health Care; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.
Topics: Adult; Benzazepines; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reward; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2013 |
Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatients.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Counseling; Female; Follow-Up Studies; Humans; Incidence; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2013 |
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline | 2013 |
Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study.
Topics: Adolescent; Adult; Benzazepines; Cognition; Double-Blind Method; Emotions; Female; Health Status; Humans; Male; Nicotinic Agonists; Quinoxalines; Reaction Time; Surveys and Questionnaires; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2013 |
Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers.
Topics: Adult; Amygdala; Benzazepines; Brain Mapping; Cross-Over Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders.
Topics: Adult; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Life Style; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Severity of Illness Index; Smoking; Smoking Cessation; Varenicline | 2012 |
Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Benzazepines; Cross-Over Studies; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Quinoxalines; Smoking; Treatment Outcome; Varenicline; Young Adult | 2013 |
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.
Topics: Adolescent; Adult; Aged; Benzazepines; Combined Modality Therapy; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Research Design; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline; Young Adult | 2012 |
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline | 2013 |
The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
Topics: Adolescent; Adult; Behavior, Addictive; Benzazepines; Cross-Over Studies; Cues; Double-Blind Method; Female; Follow-Up Studies; Humans; Imagination; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult | 2013 |
Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.
Topics: Adult; Arousal; Behavior, Addictive; Benzazepines; Cues; Female; Frontal Lobe; Functional Neuroimaging; Humans; Learning; Male; Memory; Neural Pathways; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2013 |
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
Topics: Adolescent; Adult; Amygdala; Benzazepines; Brain Mapping; Cerebral Cortex; Double-Blind Method; Down-Regulation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Rest; Smoking Cessation; Varenicline; Young Adult | 2013 |
Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzazepines; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking; Varenicline | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice.
Topics: Adolescent; Adult; Asia; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Medication Adherence; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Premedication; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.
Topics: Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Varenicline | 2013 |
Internet versus in-person counseling for patients taking varenicline for smoking cessation.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Internet; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline | 2013 |
Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial.
Topics: Adult; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
A multicentre randomized trial of combined individual and telephone counselling for smoking cessation.
Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Smoking Cessation; Smoking Prevention; Spain; Telephone; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.
Topics: Adolescent; Adult; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Parasympathetic Nervous System; Pituitary-Adrenal System; Quinoxalines; Saliva; Smoking Cessation; Varenicline; Young Adult | 2014 |
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.
Topics: Adult; Affect; Alcoholism; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Quinoxalines; Sample Size; Smoking; Socioeconomic Factors; Treatment Outcome; Varenicline | 2013 |
A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; India; Male; Placebo Effect; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult | 2014 |
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Compliance; Quinoxalines; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Varenicline | 2013 |
A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.
Topics: Adult; Benzazepines; Bipolar Disorder; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Smoking topography and abstinence in adult female smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Cues; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2013 |
Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study.
Topics: Adult; Benzazepines; Canada; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Predictive Value of Tests; Quinoxalines; Reminder Systems; Risk Assessment; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Statistics, Nonparametric; Telephone; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2013 |
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Association of deferring a quit attempt with smoking cessation success: a secondary analysis.
Topics: Adult; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Benzazepines; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mecamylamine; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Reaction Time; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Task Performance and Analysis; Varenicline | 2014 |
Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.
Topics: Adult; Aged; Benzazepines; Contracts; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Quinoxalines; Rural Population; Smoking Cessation; Thailand; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzazepines; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Severity of Illness Index; Treatment Outcome; Varenicline | 2014 |
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Methamphetamine; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline; Young Adult | 2014 |
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
Topics: Adult; Aged; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2014 |
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.
Topics: Adult; Benzazepines; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Linear Models; Male; Middle Aged; Nicotinic Agonists; Perception; Placebo Effect; Prospective Studies; Quinoxalines; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.
Topics: Adult; Benzazepines; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Taiwan; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2014 |
Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.
Topics: Benzazepines; Cardiovascular Diseases; Diet; Exercise Therapy; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2014 |
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reward; Varenicline; Young Adult | 2014 |
Effect of varenicline on aspects of inhibitory control in smokers.
Topics: Adult; Benzazepines; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Male; Neuropsychological Tests; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
Topics: Adult; Alcohol Drinking; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult | 2014 |
Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Topics: Adult; Benzazepines; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Research Design; Smoking Cessation; Socioeconomic Factors; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Varenicline | 2014 |
Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.
Topics: Benzazepines; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; New York City; Nicotinic Agonists; Opiate Substitution Treatment; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Vaccines; Varenicline; Young Adult | 2014 |
Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Australia; Benzazepines; Canada; Chi-Square Distribution; Counseling; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Recurrence; Retreatment; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline; Young Adult | 2014 |
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics.
Topics: Adult; Benzazepines; Cross-Sectional Studies; Directly Observed Therapy; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Opioid-Related Disorders; Pilot Projects; Quinoxalines; Research Design; Self Administration; Smoking; Smoking Cessation; Substance Abuse Treatment Centers; Varenicline | 2014 |
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.
Topics: Acoustic Stimulation; Adult; Amphetamine-Related Disorders; Auditory Perception; Benzazepines; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Nicotinic Agonists; Nootropic Agents; Photic Stimulation; Quinoxalines; Reaction Time; Time Factors; Treatment Outcome; Varenicline; Visual Perception | 2014 |
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
Topics: Adult; Aged; Benzazepines; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline | 2014 |
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
Topics: Adult; Alcoholism; Benzazepines; Brain; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement.
Topics: Adult; Benzazepines; Double-Blind Method; Economics, Behavioral; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Varenicline | 2014 |
Early quit days among methadone-maintained smokers in a smoking cessation trial.
Topics: Adult; Benzazepines; Female; Humans; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Quinoxalines; Self Efficacy; Smoking; Smoking Cessation; Time Factors; Varenicline | 2014 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Benzazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).
Topics: Adult; Aged; Benzazepines; Counseling; Female; Headache; Hospitalization; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2014 |
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers.
Topics: Adult; Affect; Alcohol-Related Disorders; Benzazepines; Comorbidity; Craving; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult | 2014 |
Organic cation transporter variation and response to smoking cessation therapies.
Topics: Adult; Benzazepines; Female; Genetic Variation; Humans; Male; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 2; Polymorphism, Single Nucleotide; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.
Topics: Adolescent; Adult; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2015 |
Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study.
Topics: Affect; Benzazepines; Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Craving; Cues; England; Humans; Magnetic Resonance Imaging; Nicotinic Agonists; Quinoxalines; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Stroop Test; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
[Smoking cessation: varenicline/nicotine patch combination more effective than varenicline alone].
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2014 |
Impact of cigarette smoking cessation on high-density lipoprotein functionality.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Cutaneous; Adult; Apolipoprotein A-I; Benzazepines; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholinergic Agonists; Female; Humans; Inflammation; Lipid Peroxidation; Lipids; Lipoproteins, HDL; Macrophages; Male; Malondialdehyde; Middle Aged; Nicotine; Oxidation-Reduction; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial.
Topics: Adult; Analgesics, Opioid; Benzazepines; Chronic Pain; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Opioid-Related Disorders; Pain Measurement; Pilot Projects; Quinoxalines; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2015 |
Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial.
Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Failure; Varenicline | 2015 |
Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
Topics: Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; Nicotinic Agonists; Progesterone; Quinoxalines; Smoking Cessation; Transdermal Patch; Treatment Outcome; Varenicline; Women's Health | 2015 |
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial.
Topics: Adult; Algorithms; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Medication adherence and rate of nicotine metabolism are associated with response to treatment with varenicline among smokers with HIV.
Topics: Adolescent; Benzazepines; HIV Infections; Humans; Medication Adherence; Nicotine; Nicotinic Agonists; Quinoxalines; Smokers; Varenicline | 2021 |
The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure.
Topics: Adult; Benzazepines; Craving; Cues; Double-Blind Method; Female; Humans; Laboratories; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Retrospective Studies; Smokers; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2021 |
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial).
Topics: Adult; Alkaloids; Azocines; Benzazepines; Double-Blind Method; Humans; Quinolizines; Quinoxalines; Smokers; Treatment Outcome; Varenicline | 2021 |
Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors.
Topics: Bayes Theorem; Benzazepines; Bupropion; Double-Blind Method; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Varenicline | 2021 |
Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study).
Topics: Benzazepines; Bupropion; Humans; Internet; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2022 |
Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving.
Topics: Adult; Benzazepines; Cigarette Smoking; Craving; Humans; Quinoxalines; Recurrence; Smoking Cessation; Varenicline | 2022 |
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Topics: Benzazepines; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2022 |
Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial.
Topics: Animals; Benzazepines; Female; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2022 |
Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
Topics: Adult; Benzazepines; Depressive Disorder, Major; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2023 |
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial.
Topics: Benzazepines; Counseling; Double-Blind Method; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Vaping; Varenicline | 2023 |
462 other study(ies) available for quinoxalines and varenicline
| Article | Year |
|---|---|
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Topics: Animals; Benzazepines; Cell Line; Cerebral Cortex; Humans; In Vitro Techniques; Nicotinic Agonists; Oocytes; Quinoxalines; Radioligand Assay; Rats; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus laevis | 2005 |
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Topics: Adolescent; Adult; Aged; Benzazepines; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Minnesota; Nicotinic Agonists; Psychometrics; Quinoxalines; Reproducibility of Results; Severity of Illness Index; Sickness Impact Profile; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.
Topics: Administration, Oral; Animals; Area Under Curve; Benzazepines; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Feces; Female; Glucuronides; Half-Life; Haplorhini; Humans; Male; Mass Spectrometry; Mice; Monosaccharides; Nicotinic Agonists; Pentoses; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Species Specificity; Varenicline | 2006 |
FDA speeds smoking cessation drug review.
Topics: Benzazepines; Drug Approval; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2006 |
The neurobiological basis for partial agonist treatment of nicotine dependence.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2006 |
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Neurons; Nicotinic Agonists; Oocytes; Quinoxalines; Rats; Receptors, Nicotinic; Varenicline; Xenopus laevis | 2006 |
Molecule of the Month. Varenicline tartrate.
Topics: Benzazepines; Double-Blind Method; Drug Approval; Drugs, Investigational; Follow-Up Studies; Humans; Molecular Structure; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome; United States; United States Food and Drug Administration; Varenicline | 2006 |
Varenicline for smoking cessation: definite promise, but no panacea.
Topics: Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Varenicline.
Topics: Benzazepines; Clinical Trials as Topic; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2006 |
Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Appetitive Behavior; Azetidines; Benzazepines; Corpus Striatum; Cystine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Motivation; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline | 2007 |
Trials that matter: varenicline: a designer drug to help smokers quit.
Topics: Benzazepines; Designer Drugs; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2006 |
Mechanism of varenicline (clinical ramifications): electron transfer and oxidative stress.
Topics: Benzazepines; Electron Transport; Humans; Models, Chemical; Nicotinic Agonists; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinoxalines; Varenicline | 2007 |
Efficacy of varenicline for smoking cessation.
Topics: Benzazepines; Humans; Mental Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2006 |
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Topics: Animals; Behavior, Animal; Benzazepines; Brain; Cell Line, Transformed; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; In Vitro Techniques; Male; Membrane Potentials; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Protein Binding; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self Administration; Smoking Cessation; Transfection; Varenicline | 2007 |
New prescription drug available to help smokers stop.
Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking; Varenicline | 2006 |
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.
Topics: Benzazepines; Clinical Trials as Topic; Cyclosporins; Data Collection; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Approval; Drug Evaluation; Drug Labeling; Echinocandins; Everolimus; Humans; Investigational New Drug Application; Lipopeptides; Lipoproteins; Micafungin; Peer Review; Peptides, Cyclic; Pharmacokinetics; Pharmacology, Clinical; Quinoxalines; Risk Assessment; Sirolimus; Treatment Outcome; United States; United States Food and Drug Administration; Varenicline | 2007 |
Drug approvals.
Topics: Acetanilides; Alprostadil; Angina Pectoris; Benzazepines; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Fatty Acids; Herpes Zoster Vaccine; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Ibandronic Acid; Insulin; Lubiprostone; Naltrexone; Narcotic Antagonists; Nurse's Role; Papillomavirus Vaccines; Patient Education as Topic; Piperazines; Quinoxalines; Ranolazine; Triazoles; United States; United States Food and Drug Administration; Varenicline | 2007 |
[Champix has become a registered drug].
Topics: Benzazepines; Drug Approval; European Union; Humans; Hungary; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2007 |
Comment: Oral varenicline for smoking cessation.
Topics: Benzazepines; Drug Administration Schedule; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Varenicline (CHANTIX): a stop-smoking pill.
Topics: Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2006 |
[The path from cigarettes--with support it works better].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
[Tobacco use prevention and cessation in the dental practice].
Topics: Behavior Therapy; Benzazepines; Bupropion; Dentist-Patient Relations; Health Plan Implementation; Humans; Interview, Psychological; Mouth Neoplasms; Nicotinic Agonists; Obesity; Periodontitis; Professional Role; Quinoxalines; Self Efficacy; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline; Weight Gain | 2007 |
[Drug of the month. Varenicline (Champix)].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
The pharmacist's role in tobacco cessation: overview and introduction to the series.
Topics: Benzazepines; Humans; Pharmacists; Professional Role; Quinoxalines; Tobacco Use Cessation; Varenicline | 2007 |
Why choose varenicline (chantix) for smoking cessation treatment?
Topics: Benzazepines; Choice Behavior; Counseling; Drug Monitoring; Humans; Patient Education as Topic; Patient Selection; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
[Giving up smoking is crucial for COPD patients].
Topics: Benzazepines; Bupropion; Family Practice; Humans; Patient Care Team; Patient Education as Topic; Physician-Patient Relations; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline | 2007 |
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
Topics: Animals; Appetite; Behavior, Addictive; Behavior, Animal; Benzazepines; Ethanol; Male; Naltrexone; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Sensitivity and Specificity; Sucrose; Varenicline; Water | 2007 |
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Smoking cessation update.
Topics: Adolescent; Adult; Benzazepines; Humans; Quinoxalines; Smoking; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2007 |
How well does the new drug varenicline work for people who want to stop smoking?
Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
Varenicline-induced manic episode in a patient with bipolar disorder.
Topics: Benzazepines; Bipolar Disorder; Humans; Male; Middle Aged; Quinoxalines; Recurrence; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2007 |
Exacerbation of schizophrenia by varenicline.
Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline | 2007 |
An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals.
Topics: Aerobiosis; Anaerobiosis; Androstadienes; Azithromycin; Benzazepines; Biodegradation, Environmental; Carbon Isotopes; Europe; Geologic Sediments; Government Regulation; Pharmaceutical Preparations; Quinoxalines; Reference Standards; Risk Assessment; Varenicline; Water | 2007 |
N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet.
Topics: Benzazepines; Chemistry, Pharmaceutical; Dimerization; Drug Stability; Oxidation-Reduction; Polyethylene Glycols; Quinoxalines; Tablets; Varenicline | 2008 |
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Drug Combinations; Drug Interactions; Humans; Male; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Smoking cessation: tactics that make a big difference.
Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyline; Patient Education as Topic; Quinoxalines; Smoking Cessation; Social Support; Varenicline | 2007 |
A new medication for the worst addiction.
Topics: Benzazepines; Bupropion; Drug Administration Schedule; Follow-Up Studies; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
A second varenicline trial.
Topics: Benzazepines; Bupropion; Delayed-Action Preparations; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Varenicline as maintenance therapy.
Topics: Benzazepines; Double-Blind Method; Follow-Up Studies; Humans; Long-Term Care; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
[Varenicline].
Topics: Benzazepines; Drug Monitoring; France; Humans; Nurse's Role; Patient Education as Topic; Patient Selection; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Topics: Adult; Benzazepines; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; London; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
[New drugs; varenicline].
Topics: Benzazepines; Humans; Nausea; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2007 |
[Varenicline--a new drug for smoking cessation].
Topics: Benzazepines; Humans; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Topics: Benzazepines; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Time Factors; Varenicline | 2008 |
Hypomania with agitation associated with varenicline use in bipolar II disorder.
Topics: Adult; Benzazepines; Bipolar Disorder; Female; Humans; Psychomotor Agitation; Quinoxalines; Smoking; Varenicline | 2008 |
The truth about smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Varenicline: a new pharmaceutical approach to smoking cessation.
Topics: Benzazepines; Controlled Clinical Trials as Topic; Health Knowledge, Attitudes, Practice; Humans; Nurse-Patient Relations; Nurse's Role; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; United States; Varenicline | 2008 |
Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cost of Illness; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Econometric; Morbidity; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Sweden; Value of Life; Varenicline | 2008 |
FDA warns of adverse events linked to smoking cessation drug and antiepileptics.
Topics: Anticonvulsants; Benzazepines; Humans; Mental Disorders; Quinoxalines; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2008 |
Breaking away from a narrow prescribing protocol for medicinal nicotine.
Topics: Administration, Cutaneous; Adult; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2008 |
Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.
Topics: Benzazepines; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Genotype; Humans; Pharmacogenetics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2008 |
Drug addiction: a critical problem calling for novel solutions.
Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline | 2008 |
Stat bite: Medicaid coverage of tobacco-dependence treatments.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Male; Medicaid; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Tobacco Use Disorder; United States; Varenicline | 2008 |
Smoking cessation 2008.
Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline | 2008 |
The cost effectiveness of varenicline for smoking cessation.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Surveys; Humans; Male; Medicaid; Middle Aged; Models, Econometric; Quinoxalines; Smoking Cessation; United States; Varenicline | 2007 |
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Empowering dental hygienists: tobacco cessation resources.
Topics: Benzazepines; Dental Hygienists; Humans; Mental Disorders; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2008 |
Varenicline for smoking cessation.
Topics: Adult; Benzazepines; Drug Costs; Humans; Meta-Analysis as Topic; Nicotinic Antagonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation.
Topics: Adipose Tissue, Brown; Animals; Benzazepines; Dose-Response Relationship, Drug; Female; Lipoma; Male; Mediastinal Neoplasms; Nicotine; Nicotinic Agonists; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Sex Factors; Smoking Cessation; Varenicline | 2008 |
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2008 |
Exacerbation of recurrent depression as a result of treatment with varenicline.
Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline | 2008 |
Updated US smoking cessation guideline advises counseling, combining therapies.
Topics: Behavior Therapy; Benzazepines; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; United States; Varenicline | 2008 |
New kid on the block: Chantix for smoking cessation.
Topics: Administration, Oral; Benzazepines; Drug Administration Schedule; Drug Approval; Humans; Nausea; Quinoxalines; Receptors, Cholinergic; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Varenicline | 2008 |
Varenicline reduced smoking behaviour in a mentally ill person.
Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline | 2008 |
Varenicline efficacy and tolerability in a subject with schizophrenia.
Topics: Adult; Benzazepines; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2008 |
Diffuse exanthema in a patient receiving varenicline.
Topics: Aged; Benzazepines; Exanthema; Female; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Varenicline (Chantix) warnings: risk versus benefit.
Topics: Benzazepines; Drug Partial Agonism; Humans; Mental Disorders; Nicotinic Agonists; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
The place of varenicline in smoking cessation treatment.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Drug Costs; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Clinically significant outcomes in smoking cessation.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2008 |
The influence of acute varenicline administration on smoking and eating behavior in humans.
Topics: Adult; Benzazepines; Carbon Monoxide; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Feeding Behavior; Female; Humans; Male; Methylphenidate; Quinoxalines; Smoking; Surveys and Questionnaires; Varenicline | 2008 |
Varenicline treatment for smokers with schizophrenia: a case series.
Topics: Benzazepines; Cholinergic Agonists; Drug Administration Schedule; Humans; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
The risk-benefit balance of varenicline for smoking cessation.
Topics: Benzazepines; Humans; Quinoxalines; Risk Assessment; Smoking Cessation; Varenicline | 2008 |
Varenicline and suicidality: a new era in medication safety surveillance.
Topics: Adverse Drug Reaction Reporting Systems; Benzazepines; Depression; Drug Labeling; Humans; Psychomotor Agitation; Quinoxalines; Smoking Cessation; Suicide; Suicide Prevention; Varenicline | 2008 |
Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome.
Topics: Ataxia; Benzazepines; Brain; Dreams; Fragile X Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Postural Balance; Quinoxalines; Smoking; Smoking Cessation; Tremor; Varenicline | 2009 |
First in class.
Topics: Benzazepines; Humans; Psychoses, Substance-Induced; Quinoxalines; Receptors, Nicotinic; Seizures; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2008 |
[Varenicline for smoking cessation].
Topics: Benzazepines; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Smoking cessation: the psychiatrist's role.
Topics: Antimanic Agents; Benzazepines; Bipolar Disorder; Bupropion; Humans; Lithium Carbonate; Psychiatry; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Drug Administration Schedule; Male; Motor Activity; Nicotine; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Varenicline | 2008 |
Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Nicotinic; Varenicline | 2009 |
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Topics: Animals; Behavior, Animal; Benzazepines; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Quinoxalines; Tobacco Use Disorder; Varenicline | 2008 |
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Varenicline-associated acute renal failure.
Topics: Acute Kidney Injury; Benzazepines; Creatinine; Drug Monitoring; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Varenicline | 2008 |
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2008 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
Smoking cessation: new ways to quit.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Behavior, Addictive; Benzazepines; Bupropion; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Varenicline and smokers with mental illnesses.
Topics: Benzazepines; Humans; Mental Disorders; Patient Selection; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Varenicline | 2008 |
[Drug treatment for smoking and marijuana abuse].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Humans; Marijuana Abuse; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2008 |
The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
Topics: Animals; Benzazepines; Central Nervous System Depressants; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Limbic System; Male; Microdialysis; Nicotine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Smoking Cessation; Varenicline | 2009 |
A 51-year-old woman with bipolar disorder who wants to quit smoking.
Topics: Benzazepines; Bipolar Disorder; Bupropion; Counseling; Female; Humans; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2009 |
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.
Topics: Animals; Antidepressive Agents; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming; Varenicline | 2009 |
Acute generalized exanthematous pustulosis caused by varenicline.
Topics: Adult; Benzazepines; Biopsy; Drug Eruptions; Female; Humans; Nicotinic Agonists; Psoriasis; Quinoxalines; Skin; Smoking Cessation; Varenicline | 2009 |
Varenicline and adult ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzazepines; Female; Humans; Nicotinic Antagonists; Psychiatric Status Rating Scales; Quinoxalines; Varenicline | 2008 |
Varenicline, appetite, and weight reduction.
Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss | 2008 |
Suicidal ideation and varenicline: a possible case of mistaken adverse drug reaction?
Topics: Adult; Benzazepines; Humans; Male; Quinoxalines; Self-Injurious Behavior; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Suicide; Suicide Prevention; Varenicline | 2008 |
Varenicline for tobacco dependence.
Topics: Affect; Behavior; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Suicide; Tobacco Use Disorder; Varenicline | 2009 |
Antismoking drug still recommended to Canadians despite side effects and US advisory.
Topics: Benzazepines; Canada; Humans; Quinoxalines; Smoking Cessation; United States; Varenicline | 2009 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Humans; Mental Disorders; Nicotinic Agonists; Quinoxalines; Smoking; Suicide; Tobacco Use Disorder; Varenicline | 2009 |
[Varenicline - pharmacological therapy of tobacco dependence].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Clinical Trials as Topic; Contraindications; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Pregnancy; Prospective Studies; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Persistent genital arousal disorder: a case report in a woman with lifelong PGAD where serendipitous administration of varenicline tartrate resulted in symptomatic improvement.
Topics: Benzazepines; Central Nervous System Agents; Female; Humans; Middle Aged; Quinoxalines; Receptors, Dopamine; Receptors, Nicotinic; Sexual Dysfunctions, Psychological; Smoking Cessation; Varenicline | 2009 |
Smoking cessation with varenicline: a suicidal fatality.
Topics: Adult; Benzazepines; Fatal Outcome; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Suicide; Tandem Mass Spectrometry; Varenicline | 2009 |
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Varenicline overdose in a teenager.
Topics: Adolescent; Antidotes; Benzazepines; Charcoal; Drug Overdose; Emergency Service, Hospital; Female; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Treatment Outcome; Varenicline | 2009 |
Studies linking smoking-cessation drug with suicide risk spark concerns.
Topics: Adverse Drug Reaction Reporting Systems; Affect; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Risk; Smoking Cessation; Suicide; United States; Varenicline; Wounds and Injuries | 2009 |
[Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Spain; Varenicline; Young Adult | 2008 |
Varenicline augmentation in depressed smokers: an 8-week, open-label study.
Topics: Adolescent; Adult; Aged; Benzazepines; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychotropic Drugs; Quinoxalines; Receptors, Nicotinic; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Combination treatment with varenicline and nicotine replacement therapy.
Topics: Adult; Aged; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.
Topics: Adult; Antipsychotic Agents; Benzazepines; Humans; Male; Psychiatric Status Rating Scales; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Varenicline | 2009 |
Two recent updates for psychiatric conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |
Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzazepines; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline; Veterans | 2009 |
Findings on alcohol dependence point to promising avenues for targeted therapies.
Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline | 2009 |
Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Topics: Animals; Benzazepines; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Male; Medial Forebrain Bundle; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Nicotinic; Reward; Varenicline | 2009 |
Hallucinations in the context of varenicline withdrawal.
Topics: Adult; Benzazepines; Cholinergic Agonists; Hallucinations; Humans; Male; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Reduced affective symptoms during tobacco dependence treatment with varenicline.
Topics: Affective Symptoms; Benzazepines; Depressive Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link?
Topics: Benzazepines; Humans; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Suicide; United Kingdom; Varenicline | 2009 |
Treatment of comorbid tobacco use in people with serious mental illness.
Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline | 2009 |
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.
Topics: Adult; Benzazepines; Drug Prescriptions; Drug Utilization; England; Family Practice; Female; Humans; Male; Middle Aged; Quinoxalines; Safety; Smoking Cessation; Varenicline | 2009 |
Does varenicline induce acute interstitial nephritis?
Topics: Acute Disease; Benzazepines; Humans; Male; Middle Aged; Nephritis, Interstitial; Prednisone; Quinoxalines; Varenicline | 2009 |
Varenicline and proximal myopathy.
Topics: Adult; Benzazepines; Follow-Up Studies; Humans; Male; Myotonic Disorders; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Chantix-induced mental status changes in a young healthy female.
Topics: Benzazepines; Female; Humans; Nicotinic Antagonists; Paranoid Disorders; Quinoxalines; Varenicline; Young Adult | 2009 |
Varenicline-induced acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Benzazepines; Diagnosis, Differential; Drug Eruptions; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Varenicline | 2009 |
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult | 2009 |
Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix).
Topics: Benzazepines; Friedreich Ataxia; Humans; Male; Middle Aged; Nicotinic Agonists; Proprioception; Quinoxalines; Siblings; Varenicline | 2009 |
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
Topics: Affect; Alcohol Drinking; Animals; Attention; Benzazepines; Cerebral Cortex; Cognition; Depression; Drug Partial Agonism; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Recognition, Psychology; Reflex, Startle; Reward; Tobacco Use Disorder; Varenicline | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Cost-effectiveness of varenicline for smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence.
Topics: Adolescent; Adult; Aged; Benzazepines; Costs and Cost Analysis; Female; Humans; Male; Middle Aged; Models, Theoretical; Quinoxalines; Smoking; Smoking Cessation; Sweden; Treatment Outcome; Varenicline; Young Adult | 2009 |
Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Varenicline overdose in a teenager--a clinical pharmacology perspective.
Topics: Adolescent; Benzazepines; Drug Overdose; Humans; Nausea; Poisoning; Quinoxalines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Varenicline; Vomiting | 2009 |
Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
Topics: Acute Disease; Benzazepines; Hepatitis C; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Varenicline increases striatal dopamine D(2/3) receptor binding in rats.
Topics: Animals; Benzamides; Benzazepines; Binding Sites; Cerebellum; Corpus Striatum; Male; Nicotinic Agonists; Pyrrolidines; Quinoxalines; Radiopharmaceuticals; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Varenicline | 2009 |
Safety of smoking cessation drugs.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use.
Topics: Benzazepines; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Middle Aged; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
Topics: Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; Directive Counseling; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline | 2009 |
Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.
Topics: Accidents, Traffic; Benzazepines; Bupropion; Drug Labeling; Humans; Neurotransmitter Agents; Quinoxalines; Receptors, Nicotinic; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2009 |
[Tolerability profile of varenicline in current medical practice].
Topics: Adult; Benzazepines; Female; France; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Metabolic Diseases; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Skin Diseases; Smoking; Varenicline | 2010 |
Smoking cessation: how to advise the patient.
Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.
Topics: Adult; Affective Disorders, Psychotic; Benzazepines; Humans; Male; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Varenicline | 2009 |
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.
Topics: Animals; Benzazepines; Dopamine; Extracellular Space; Genetic Vectors; Green Fluorescent Proteins; Lentivirus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinoxalines; Receptors, Nicotinic; Varenicline | 2010 |
Smoking cessation agents and suicide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Quinoxalines; Self-Injurious Behavior; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
[Drug treatment of tobacco dependence].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Population pharmacokinetic analysis of varenicline in adult smokers.
Topics: Adult; Benzazepines; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Models, Biological; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Renal Insufficiency; Smoking; Smoking Cessation; Varenicline; Young Adult | 2009 |
A retrospective poison center review of varenicline-exposed patients.
Topics: Adolescent; Adult; Benzazepines; Child, Preschool; Databases, Factual; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infant; Male; Medication Errors; Mental Disorders; Nicotinic Agonists; Poison Control Centers; Quinoxalines; Retrospective Studies; Smoking Cessation; Varenicline | 2009 |
Varenicline and antiretroviral therapy in patients with HIV.
Topics: Anti-Retroviral Agents; Benzazepines; Cardiovascular Diseases; Female; HIV Infections; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Varenicline and suicide. Risk of psychiatric side effects with varenicline.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Risk Factors; Suicide; Varenicline | 2009 |
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
Topics: Animals; Association Learning; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Exploratory Behavior; Food; Male; Models, Animal; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Recurrence; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2010 |
Regulation of smoking cessation drugs by the Food and Drug Administration.
Topics: Benzazepines; Clinical Trials as Topic; Drug Approval; Drug Interactions; Government Regulation; Humans; Mental Disorders; Nicotinic Agonists; Product Surveillance, Postmarketing; Psychotropic Drugs; Quinoxalines; Smoking; Smoking Cessation; United States; United States Food and Drug Administration; Varenicline | 2009 |
Varenicline and suicide. Safety data from New Zealand.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cause of Death; Cohort Studies; Female; Humans; Male; Middle Aged; New Zealand; Nicotinic Agonists; Quinoxalines; Risk Assessment; Suicide; Varenicline; Young Adult | 2009 |
Varenicline for smoking cessation in patients with coronary heart disease.
Topics: Benzazepines; Cardiovascular Diseases; Coronary Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Costs and Cost Analysis; Databases, Factual; Dopamine Uptake Inhibitors; Female; Finland; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
Topics: Alcohol Drinking; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Choice Behavior; Dose-Response Relationship, Drug; Drinking Behavior; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Varenicline | 2010 |
Varenicline effects on cocaine self administration and reinstatement behavior.
Topics: Animals; Behavior, Addictive; Benzazepines; Cocaine; Conditioning, Operant; Cues; Extinction, Psychological; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Long-Evans; Secondary Prevention; Self Administration; Varenicline | 2010 |
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
Topics: Acetylcholine; Alkaloids; Animals; Azocines; Benzazepines; Decamethonium Compounds; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electrophysiology; Gene Expression; Hexamethonium; Humans; Mecamylamine; Mice; Mice, Transgenic; Muscle, Skeletal; Nicotinic Antagonists; Oocytes; Quinolizines; Quinoxalines; Rats; Receptors, Nicotinic; Varenicline; Xenopus laevis | 2010 |
Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study.
Topics: Benzazepines; Family Practice; Female; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Motivation; Nicotinic Agonists; Prevalence; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; United Kingdom; Varenicline | 2010 |
Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
Topics: Antipsychotic Agents; Benzazepines; Drinking; Drug Therapy, Combination; Humans; Hyponatremia; Male; Middle Aged; Nicotinic Agonists; Psychoses, Substance-Induced; Quinoxalines; Schizophrenia; Smoking Cessation; Varenicline; Water Intoxication | 2010 |
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Male; Mesalamine; Methyltransferases; Mutation; Neutrophils; Nicotinic Agonists; Prednisolone; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2010 |
Varenicline and pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Benzazepines; Female; Humans; Middle Aged; Nicotinic Agonists; Pheochromocytoma; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2010 |
Integrating smoking cessation into HIV care.
Topics: Anti-HIV Agents; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Government Programs; HIV Infections; Humans; Nicotinic Agonists; Oregon; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2010 |
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Topics: Animals; Benzazepines; Conditioning, Classical; Dose-Response Relationship, Drug; Male; Mecamylamine; Morphine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Tobacco Use Disorder; Varenicline | 2010 |
Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
Topics: Animals; Benzazepines; Conditioning, Classical; Discrimination, Psychological; Extinction, Psychological; Generalization, Psychological; Isoxazoles; Ligands; Male; Nicotine; Nicotinic Agonists; Pyrrolidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline | 2010 |
Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence.
Topics: Adult; Benzazepines; Female; Humans; Male; Prospective Studies; Quinoxalines; Retrospective Studies; Reward; Single-Blind Method; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2010 |
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Azepines; Azocines; Benzazepines; Brain; Dopamine; Heterocyclic Compounds, 4 or More Rings; Humans; Limbic System; Male; Mice; Mice, Knockout; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2010 |
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
Topics: Benzazepines; Cotinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Gene Expression; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; RNA, Messenger; Schizophrenia; Smoking Cessation; Varenicline | 2010 |
Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Topics: Adult; Aged; Benzazepines; Brain-Derived Neurotrophic Factor; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Humans; Male; Montana; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation.
Topics: Adult; Antidepressive Agents; Benzazepines; Depressive Disorder; Humans; Male; Quinoxalines; Sertraline; Smoking Cessation; Varenicline | 2010 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |
Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Topics: Analgesics, Opioid; Animals; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Mice; Morphine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Varenicline | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
Varenicline withdrawal-induced delirium with psychosis.
Topics: Adult; Benzazepines; Delirium; Female; Humans; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Substance Withdrawal Syndrome; Varenicline | 2010 |
Varenicline-induced drug eruption with resulting palmar/plantar hyperhidrosis and dysesthesia.
Topics: Adult; Benzazepines; Drug Eruptions; Female; Foot; Glucocorticoids; Hand; Humans; Hyperhidrosis; Nicotinic Agonists; Paresthesia; Prednisolone; Quinoxalines; Varenicline | 2010 |
Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Drug Costs; Drug Labeling; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; Time Factors; Varenicline; Young Adult | 2010 |
The use of snus for quitting smoking compared with medicinal products.
Topics: Adult; Benzazepines; Chewing Gum; Data Collection; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Regression Analysis; Smoking Cessation; Tobacco, Smokeless; Varenicline | 2010 |
Thoughts and acts of aggression/violence toward others reported in association with varenicline.
Topics: Adult; Aggression; Benzazepines; Female; Humans; Male; Mental Disorders; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Thinking; Varenicline; Violence | 2010 |
Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
Topics: Alanine; Alcohol Drinking; Analysis of Variance; Animals; Benzazepines; Central Nervous System Depressants; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drinking Behavior; Drug Combinations; Ethanol; Gene Expression Regulation; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; Nicotinic Agonists; Proto-Oncogene Proteins c-fos; Quinoxalines; Receptors, Nicotinic; Tyrosine 3-Monooxygenase; Varenicline; Ventral Tegmental Area | 2010 |
Varenicline-induced Psychosis.
Topics: Benzazepines; Humans; Psychotic Disorders; Quinoxalines; Varenicline | 2010 |
Drug safety crackdown revs up.
Topics: Benzazepines; Female; Humans; Male; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Varenicline; Violence | 2010 |
[The management of patients with nicotine dependence - the role of the general practitioners].
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline | 2010 |
[Medical therapy for smoking cessation].
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
Topics: Animals; Azetidines; Benzazepines; Discrimination Learning; Drug Partial Agonism; Male; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Varenicline | 2010 |
Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial".
Topics: Benzazepines; Cardiovascular Diseases; Depression; Humans; Nicotinic Agonists; Patient Selection; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2010 |
Nicotine gum dependence treated with varenicline--a case report.
Topics: Adult; Benzazepines; Female; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.
Topics: Animals; Behavior, Animal; Benzazepines; Cholinergic Agents; Cholinesterase Inhibitors; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Methamphetamine; Muscarinic Antagonists; Nicotinic Agonists; Nicotinic Antagonists; Pentobarbital; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Varenicline | 2010 |
Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
Topics: Adult; Benzazepines; Cohort Studies; Drug Therapy; Female; Humans; Insurance Claim Review; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; United States; Varenicline | 2010 |
Clinical experience of varenicline for smoking cessation.
Topics: Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outpatient Clinics, Hospital; Patient Compliance; Quinoxalines; Republic of Korea; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2010 |
Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Varenicline | 2011 |
Electroconvulsive therapy (ECT) effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient.
Topics: Benzazepines; Electroconvulsive Therapy; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking Cessation; Suicidal Ideation; Varenicline | 2010 |
The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice.
Topics: Animals; Ataxia; Benzazepines; Drug Evaluation, Preclinical; Drug Partial Agonism; Drug Synergism; Ethanol; Female; Hypnotics and Sedatives; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nicotinic Agonists; Quinoxalines; Reflex, Righting; Varenicline | 2010 |
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult | 2011 |
Mental health stability in veterans with posttraumatic stress disorder receiving varenicline.
Topics: Benzazepines; Female; Hospitals, Veterans; Humans; Male; Mental Health Services; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Varenicline; Veterans | 2010 |
The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
Topics: Aconitine; Amphetamine; Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Female; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Varenicline | 2011 |
Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Topics: Animals; Antidepressive Agents; Benzazepines; Biogenic Monoamines; Chromatography, High Pressure Liquid; Clorgyline; Data Interpretation, Statistical; Dopamine; Drug Interactions; Extracellular Space; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Nicotinic Agonists; Norepinephrine; Prefrontal Cortex; Quinoxalines; Rats; Rats, Wistar; Serotonin; Sertraline; Varenicline; Vesicular Monoamine Transport Proteins | 2011 |
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
Topics: Animals; Benzazepines; Cerebral Cortex; Hippocampus; Male; Mice; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Thalamus; Up-Regulation; Varenicline | 2011 |
Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Topics: Aged; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Benzazepines; Carbamates; Cell Line, Tumor; Cells, Cultured; Frontal Lobe; Humans; Neurons; Nicotinic Agonists; PC12 Cells; Quinoxalines; Quinuclidines; Rats; Receptors, Nicotinic; Varenicline | 2011 |
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors; Tobacco Use Disorder; Varenicline | 2011 |
Drug treatment for users of smokeless tobacco.
Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2010 |
[Sustainable efficacy of oral varenicline for smoking cessation].
Topics: Administration, Oral; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2010 |
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2011 |
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Reinforcement Schedule; Smoking Cessation; Time Factors; Varenicline | 2011 |
Prescription drugs associated with reports of violence towards others.
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzazepines; Humans; Hypnotics and Sedatives; Outcome Assessment, Health Care; Pharmaceutical Preparations; Prescription Drugs; Prospective Studies; Quinoxalines; United States; United States Food and Drug Administration; Varenicline; Violence | 2010 |
Varenicline (champix)-associated manic relapse in bipolar affective disorder.
Topics: Benzazepines; Bipolar Disorder; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
Australia's experience with varenicline: usage, costs and adverse reactions.
Topics: Australia; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2011 |
Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Azetidines; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Levodopa; Male; Nicotinic Agonists; Oxidopamine; Parkinson Disease; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline | 2011 |
Adynamic ileus induced by varenicline.
Topics: Aged; Benzazepines; Humans; Ileus; Male; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Pharmacotherapy for smoking.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2011 |
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus | 2011 |
Varenicline-induced grand mal seizure.
Topics: Benzazepines; Diagnosis, Differential; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Tonic-Clonic; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey.
Topics: Adult; Age Factors; Australia; Benzazepines; Canada; Cohort Studies; Cross-Cultural Comparison; Cross-Sectional Studies; Drug Utilization; Female; Health Surveys; Humans; International Cooperation; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Self Report; Sex Factors; Smoking Cessation; Socioeconomic Factors; United Kingdom; United States; Varenicline | 2011 |
Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
Topics: Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Ethanol; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Recurrence; Reinforcement Schedule; Self Administration; Sucrose; Varenicline | 2011 |
Effectiveness of varenicline for smoking cessation: a 1-year follow-up study.
Topics: Adult; Benzazepines; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons.
Topics: Analysis of Variance; Animals; Azetidines; Behavior, Animal; Benzazepines; Cerebral Cortex; Conditioning, Classical; Cues; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Epigenomics; Exploratory Behavior; Fear; Freezing Reaction, Cataleptic; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamate Decarboxylase; Male; Mecamylamine; Methyl-CpG-Binding Protein 2; Mice; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Promoter Regions, Genetic; Quinoxalines; Receptors, Nicotinic; RNA, Messenger; Varenicline | 2011 |
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2011 |
Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
Topics: Alcohol Drinking; Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Neurons; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Stimulation, Chemical; Varenicline | 2011 |
Prescribing of smoking cessation medication in England since the introduction of varenicline.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline | 2011 |
Varenicline induced mania in a 51 year old patient without history of bipolar illness.
Topics: Benzazepines; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Nicotinic Agonists; Paranoid Disorders; Patient Admission; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Correlation between willing to smoking cessation and treatment outcome of health care workers in Thailandt.
Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Follow-Up Studies; Health Personnel; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Patient Acceptance of Health Care; Prospective Studies; Quinoxalines; Smoking; Smoking Cessation; Surveys and Questionnaires; Thailand; Treatment Outcome; Varenicline; Young Adult | 2011 |
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Topics: Adult; Benzazepines; Clinical Trials as Topic; Female; Health Care Costs; Humans; Male; Models, Statistical; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD?
Topics: Benzazepines; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2011 |
A case of late-life onset mania during Varenicline assisted smoking cessation.
Topics: Age of Onset; Aged; Antimanic Agents; Antipsychotic Agents; Benzazepines; Bipolar Disorder; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2011 |
Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
Topics: Animals; Antidepressive Agents; Azetidines; Behavior, Animal; Benzazepines; Brain; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Motor Activity; Nicotinic Agonists; Protein Binding; Pyridines; Quinoxalines; Receptors, Nicotinic; Swimming; Time Factors; Varenicline | 2011 |
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims.
Topics: Adolescent; Adult; Aged; Benzazepines; Cohort Studies; Cost Sharing; Female; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; United States; Varenicline; Young Adult | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline | 2011 |
Core modification of cytisine: a modular synthesis.
Topics: Alkaloids; Azocines; Benzazepines; Cyclization; Nicotinic Agonists; Pyridones; Quinolizines; Quinoxalines; Receptors, Nicotinic; Tin Compounds; Varenicline | 2011 |
A comparison of brain and behavioral effects of varenicline and nicotine in rats.
Topics: Animals; Benzazepines; Brain; Brain Mapping; Drug Administration Schedule; Drug Tolerance; Injections, Intravenous; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Maze Learning; Motor Activity; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline | 2011 |
Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
Topics: Adult; Benzazepines; Bupropion; Drug Utilization; England; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2011 |
Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales | 2011 |
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult | 2011 |
Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
Topics: Adult; Analysis of Variance; Benzazepines; Cognition; Humans; Male; Middle Aged; Mood Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2011 |
Smoking cessation pharmacotherapy: a concise overview.
Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2011 |
Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.
Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Psychomotor Performance; Quinoxalines; Reward; Schizophrenia; Smoking; Smoking Cessation; Varenicline | 2012 |
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult | 2012 |
Varenicline for smoking cessation: is it a heartbreaker?
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
Topics: Animals; Benzazepines; Bridged Bicyclo Compounds, Heterocyclic; Cytosine; Data Interpretation, Statistical; Dihydro-beta-Erythroidine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Varenicline | 2011 |
The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
Topics: Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Evoked Potentials, Auditory; Male; Mice; Mice, Inbred DBA; Neural Inhibition; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2011 |
Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.
Topics: Amino Acid Sequence; Animals; Benzazepines; Binding Sites; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Granisetron; HEK293 Cells; Humans; Membrane Potentials; Mice; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinoxalines; Radioligand Assay; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Species Specificity; Varenicline; Xenopus laevis | 2011 |
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Prospective Studies; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult | 2011 |
Treatment of nicotine dependence with Chantix (varenicline).
Topics: Adult; Benzazepines; Disclosure; Drug Interactions; Humans; Mental Disorders; Nausea; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
Topics: Animals; Benzazepines; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dopamine Uptake Inhibitors; Macaca mulatta; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Reinforcement, Psychology; Self Administration; Time Factors; Varenicline | 2011 |
In brief: Cardiovascular safety of varenicline (Chantix).
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.
Topics: Benzazepines; Double-Blind Method; Humans; Motivation; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Varenicline | 2011 |
Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Policy; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Varenicline; Vietnam; Young Adult | 2012 |
Varenicline: quantifying the risk.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Varenicline: quantifying the risk.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Varenicline: quantifying the risk.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Varenicline: quantifying the risk.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Varenicline: quantifying the risk.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
Varenicline: cardiovascular safety.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Varenicline | 2011 |
[Clinical study of smoking cessation clinic subjects].
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outpatient Clinics, Hospital; Outpatients; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.
Topics: Animals; Benzazepines; Conditioning, Operant; Cues; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Feeding Behavior; Male; Motivation; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Tobacco Use Disorder; Varenicline | 2012 |
[Smoking cessation--assistance for the general practitioner].
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2011 |
Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Topics: Adult; Benzazepines; Catecholamines; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Adult; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Topics: Benzazepines; Chromatography, High Pressure Liquid; Cotinine; Drug Stability; Humans; Linear Models; Nicotine; Quinoxalines; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Tandem Mass Spectrometry; Varenicline | 2011 |
A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
Topics: Benzazepines; Cost-Benefit Analysis; Europe; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2011 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Effects of smoking cessation on central blood pressure and arterial stiffness.
Topics: Ankle Brachial Index; Benzazepines; Blood Pressure; Brachial Artery; Chi-Square Distribution; Compliance; Female; Humans; Japan; Male; Middle Aged; Nicotinic Agonists; Pulsatile Flow; Quinoxalines; Radial Artery; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Varenicline; Ventricular Function, Left | 2011 |
The pain of giving up smoking.
Topics: Benzazepines; Female; Humans; Inferior Wall Myocardial Infarction; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2012 |
More evidence that varenicline harms the heart.
Topics: Benzazepines; Cardiovascular Diseases; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Health Behavior; Humans; Longitudinal Studies; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.
Topics: Adult; Aged; Benzazepines; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2012 |
Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
Topics: Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Paranoid Personality Disorder; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline | 2012 |
Real world evaluation of three models of NHS smoking cessation service in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Community Health Services; Counseling; England; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
New reports examine psychiatric risks of varenicline for smoking cessation.
Topics: Benzazepines; Drug Labeling; Hospitalization; Humans; Nicotinic Agonists; Quinoxalines; Reproducibility of Results; Risk; Smoking Cessation; Suicidal Ideation; Suicide; Suicide, Attempted; United States; United States Food and Drug Administration; Varenicline | 2012 |
Prescribing of nicotine replacement therapy to cardiovascular disease patients in England.
Topics: Adult; Benzazepines; Bupropion; Coronary Disease; Drug Prescriptions; England; General Practice; Humans; Nicotinic Agonists; Prescription Drugs; Quinoxalines; Regression Analysis; Smoking Cessation; Smoking Prevention; Stroke; Tobacco Use Cessation Devices; Varenicline | 2012 |
Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Female; Genotype; Hexamethonium; Hypothermia; Inhibitory Concentration 50; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Motor Activity; Mutation; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Ondansetron; Quinoxalines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Varenicline | 2012 |
Grover disease may result from the impairment of keratinocytic cholinergic receptors.
Topics: Acantholysis; Benzazepines; Humans; Ichthyosis; Keratinocytes; Male; Middle Aged; Quinoxalines; Receptors, Cholinergic; Tobacco Use Cessation Devices; Varenicline | 2012 |
Pfizer advertises smoking cessation drug despite health warnings.
Topics: Advertising; Benzazepines; Canada; Drug Industry; Humans; Quinoxalines; Tobacco Use Cessation Devices; Varenicline | 2012 |
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
Topics: Animals; Benzamides; Benzazepines; Male; Neostriatum; Nicotinic Agonists; Protein Binding; Pyrrolidines; Quinoxalines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Tomography, Emission-Computed, Single-Photon; Varenicline | 2012 |
Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzazepines; Databases, Factual; Epistaxis; Female; Hemorrhage; Humans; Male; Middle Aged; Netherlands; New Zealand; Nicotinic Agonists; Pharmacovigilance; Quinoxalines; Smoking Cessation; Varenicline; Young Adult | 2012 |
Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.
Topics: Adult; Benzazepines; Brain Injury, Chronic; Depression; Female; Humans; Male; Middle Aged; MMPI; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2012 |
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.
Topics: Adult; Affect; Alcohol Drinking; Alcohol-Related Disorders; Benzazepines; Central Nervous System Depressants; Ethanol; Eye Movements; Female; Humans; Male; Nausea; Nicotinic Agonists; Quinoxalines; Varenicline; Young Adult | 2012 |
Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Topics: Adult; Aged; Benzazepines; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.
Topics: Adult; Attitude to Health; Benzazepines; Biomarkers; Black or African American; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2012 |
A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.
Topics: Adolescent; Adult; Aged; Benzazepines; Brain; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Smoking; Varenicline | 2012 |
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Middle Aged; Nicaragua; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Stroke; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
Varenicline: aggression and homicidal ideation.
Topics: Adult; Aggression; Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2012 |
Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Hypnotics and Sedatives; Infusions, Intravenous; Male; Metyrapone; Nicotine; Oxazepam; Quinoxalines; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Smoking Cessation; Varenicline | 2012 |
The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
Topics: Benzazepines; Cardiovascular Diseases; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Varenicline | 2012 |
Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Cocaine; Conditioning, Operant; Discrimination Learning; Dopamine Uptake Inhibitors; Drug Interactions; Female; Hypnotics and Sedatives; Macaca mulatta; Male; Mecamylamine; Midazolam; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Varenicline | 2012 |
Varenicline induced psychosis in schizophrenia.
Topics: Adult; Benzazepines; Female; Humans; Nicotinic Antagonists; Psychoses, Substance-Induced; Quinoxalines; Schizophrenia; Tobacco Use Cessation Devices; Varenicline | 2012 |
Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
Topics: Animals; Benzazepines; Biological Transport; Cell Line; HEK293 Cells; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organic Cation Transport Proteins; Organic Cation Transporter 2; Quinoxalines; Varenicline | 2012 |
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Promoting smoking cessation.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Complementary Therapies; Family Practice; Female; Health Promotion; Humans; Male; Motivation; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline | 2012 |
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
Topics: Animals; Benzazepines; Corpus Striatum; Dopamine; Male; Nicotine; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Saimiri; Smoking Cessation; Synaptosomes; Varenicline | 2012 |
Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aplysia; Azocines; Benzazepines; Binding Sites; Binding, Competitive; Carrier Proteins; Cell Line; HEK293 Cells; Humans; Kinetics; Ligands; Models, Molecular; Mutation; Nicotine; Nicotinic Agonists; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2012 |
Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
Topics: Acetylcholine; Alkaloids; Animals; Azocines; Benzazepines; Drug Partial Agonism; Evoked Potentials; Ganglia; Humans; Ligands; Mutagenesis, Site-Directed; Mutant Proteins; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Protein Subunits; Quinolizines; Quinoxalines; Rats; Receptors, Nicotinic; Recombinant Fusion Proteins; Species Specificity; Varenicline; Xenopus laevis | 2012 |
Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.
Topics: Amino Acid Sequence; Animals; Benzazepines; Carrier Proteins; Crystallography, X-Ray; Electrophoresis, Polyacrylamide Gel; Ion Channels; Models, Molecular; Molecular Sequence Data; Mutagenesis; Nicotinic Agonists; Polychaeta; Quinoxalines; Receptors, Nicotinic; Sequence Analysis, DNA; Smoking; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline; Xenopus laevis | 2012 |
Fatality following a suicidal overdose with varenicline.
Topics: Adult; Benzazepines; Central Nervous System Depressants; Drug Overdose; Ethanol; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Hypothermia; Male; Nicotinic Agonists; Quinoxalines; Suicide; Varenicline; Vitreous Body | 2013 |
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
Topics: Analgesics; Animals; Azetidines; Benzazepines; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Motor Activity; Nicotinic Agonists; Pain; Pain Measurement; Pyridines; Quinoxalines; Receptors, Nicotinic; Varenicline | 2012 |
Drug-induced liver injury due to varenicline: a case report.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Benzazepines; Chemical and Drug Induced Liver Injury; Humans; International Normalized Ratio; Liver; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline; Withholding Treatment | 2012 |
Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Benzazepines; Cost-Benefit Analysis; Drug Costs; Female; Humans; Insurance, Health, Reimbursement; Insurance, Pharmaceutical Services; Male; Middle Aged; Quinoxalines; Saskatchewan; Sex Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
Effectiveness of varenicline for smoking cessation at 2 urban academic health centers.
Topics: Academic Medical Centers; Adult; Benzazepines; Female; Hospitals, Urban; Humans; Male; Poisson Distribution; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats.
Topics: Acetylcholine; Animals; Arterioles; Benzazepines; Cerebral Arteries; Cerebral Veins; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Smoking; Varenicline; Vasodilation; Vasodilator Agents | 2012 |
Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care setting.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Nicotinic Agonists; Patients; Pharmacovigilance; Primary Health Care; Product Labeling; Pyridines; Quinoxalines; Telephone; Varenicline; Young Adult; Zolpidem | 2012 |
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Military Personnel; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult | 2013 |
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Topics: Benzazepines; Bupropion; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Greece; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Models, Economic; Monte Carlo Method; Prevalence; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.
Topics: Acetylcholine; Aequorin; Algorithms; Benzazepines; Calcium; Data Interpretation, Statistical; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Permeability; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Varenicline | 2012 |
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
Topics: Adolescent; Adult; Age Distribution; Aged; Australia; Benzazepines; Bupropion; Canada; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2013 |
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
Topics: Animals; Azetidines; Behavior, Animal; Benzazepines; Binding Sites; Brain Chemistry; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Male; Membranes; Neurons; Nicotine; Nicotinic Agonists; Pregnancy; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Up-Regulation; Varenicline | 2012 |
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Bridged Bicyclo Compounds; Cocaine; Cocaine-Related Disorders; Cognition Disorders; Dopamine Uptake Inhibitors; Hippocampus; Learning; Ligands; Macaca mulatta; Male; Memory, Short-Term; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nootropic Agents; Quinoxalines; Receptors, Nicotinic; Reversal Learning; Self Administration; Varenicline | 2013 |
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline | 2012 |
Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
Topics: Adult; Benzazepines; Bipolar Disorder; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Stress Disorders, Post-Traumatic; Suicidal Ideation; Tobacco Use Disorder; United States; Varenicline; Veterans | 2012 |
Alpha oscillations in response to affective and cigarette-related stimuli in smokers.
Topics: Adult; Attention; Benzazepines; Brain; Bupropion; Cues; Demography; Electroencephalography Phase Synchronization; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Photic Stimulation; Quinoxalines; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Varenicline | 2013 |
Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
Topics: Benzazepines; Bupropion; Chromosomes, Human, Pair 15; Genetic Loci; Genome-Wide Association Study; Humans; Multigene Family; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Strategies to help a smoker who is struggling to quit.
Topics: Behavior Therapy; Benzazepines; Bupropion; Chronic Disease; Counseling; Disease Management; Dopamine Uptake Inhibitors; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Brazil; Bupropion; Demography; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2013 |
[Methods and results of smoking cessation in cancer smoker's].
Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.
Topics: Acute Coronary Syndrome; Adult; Age Distribution; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Quinoxalines; Retrospective Studies; Risk Assessment; Sex Distribution; Smoking Cessation; Stroke; Survival Analysis; Varenicline | 2012 |
Varenicline for smoking cessation.
Topics: Benzazepines; Cardiovascular Diseases; Drug Approval; Drug Monitoring; Female; Humans; Male; Needs Assessment; New Zealand; Nicotinic Agonists; Quinoxalines; Risk Assessment; Smoking Cessation; Suicidal Ideation; United States; United States Food and Drug Administration; Varenicline | 2012 |
Tracking dental patient tobacco use and intervention in the academic clinical setting.
Topics: Age of Onset; Benzazepines; Bupropion; Counseling; Dental Records; Dopamine Uptake Inhibitors; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Medical History Taking; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Referral and Consultation; Schools, Dental; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Varenicline; West Virginia | 2012 |
Smoking cessation interventions after acute coronary syndromes. Results of a cross-sectional survey in the Lazio Region of Italy.
Topics: Acute Coronary Syndrome; Benzazepines; Cross-Sectional Studies; Health Behavior; Health Care Surveys; Health Promotion; Humans; Italy; Nicotinic Agonists; Patient Discharge; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2012 |
Varenicline and bupropion: suicide.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline | 2012 |
Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzazepines; Female; Humans; Male; Memory Disorders; Middle Aged; New Zealand; Nicotinic Agonists; Quinoxalines; Varenicline | 2013 |
Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice.
Topics: Animals; Benzazepines; Male; Maze Learning; Mecamylamine; Memory; Mice; Motor Activity; Nicotine; Quinoxalines; Receptors, Cholinergic; Scopolamine; Varenicline | 2012 |
Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey.
Topics: Adult; Alcohol Drinking; Benzazepines; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
[Consensus report for the clinical care of smoking cessation in Spain. Comité Nacional para la Prevención del Tabaquismo].
Topics: Benzazepines; Bupropion; Counseling; Humans; Motivation; Nicotinic Agonists; Patient Compliance; Patient Education as Topic; Persuasive Communication; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.
Topics: Benzazepines; Cardiovascular Diseases; Comorbidity; Data Interpretation, Statistical; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Nicotinic Agonists; Opioid-Related Disorders; Prevalence; Primary Health Care; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline | 2013 |
Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Chile; Dose-Response Relationship, Drug; Drinking; Drug Administration Schedule; Ethanol; Male; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Saccharin; Time Factors; Varenicline | 2013 |
The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.
Topics: Adolescent; Adult; Aged; Benzazepines; Comprehension; Drug Labeling; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Patient Education as Topic; Patient Safety; Pharmacovigilance; Quinoxalines; Risk Assessment; Risk Factors; Risk Management; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult | 2013 |
Varenicline in autistic disorder: hypothesis and case report of single-patient crossover.
Topics: Autistic Disorder; Benzazepines; Child; Cross-Over Studies; Humans; Male; Nicotinic Agonists; Quinoxalines; Varenicline | 2013 |
Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15.
Topics: Age Factors; Animals; Behavior, Animal; Benzazepines; Butanones; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Chlorides; Fasting; Mecamylamine; Muscles; Mutation; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Protein Subunits; Quinoxalines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Nicotinic; Reward; Sodium; Taste; Time Factors; Varenicline | 2013 |
Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons.
Topics: Animals; Benzazepines; CA1 Region, Hippocampal; Female; GABAergic Neurons; Inhibitory Postsynaptic Potentials; Male; Neural Inhibition; Neurons; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Synaptic Transmission; Varenicline | 2013 |
Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure.
Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Operant; Dose-Response Relationship, Drug; Eating; Ethanol; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Inbred Lew; Self Administration; Treatment Outcome; Varenicline | 2013 |
Use of varenicline versus bupropion and risk of psychiatric adverse events.
Topics: Adult; Benzazepines; Bupropion; Denmark; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Proportional Hazards Models; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2013 |
Adherence to varenicline and associated smoking cessation in a community-based patient setting.
Topics: Adult; Benzazepines; Cohort Studies; Community Health Centers; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Pennsylvania; Primary Health Care; Provider-Sponsored Organizations; Quinoxalines; Retrospective Studies; Self Report; Smoking Cessation; Tobacco Use Disorder; Treatment Refusal; Varenicline | 2013 |
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Hyperkinesis; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Substance-Related Disorders; Tritium; Varenicline | 2013 |
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
Topics: Adult; Benzazepines; Bupropion; Comparative Effectiveness Research; Dopamine Uptake Inhibitors; Drug Therapy, Combination; England; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Dihydro-beta-Erythroidine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Morphine; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline | 2013 |
Systematic review wins CMAJ Bruce Squires Award.
Topics: Awards and Prizes; Benzazepines; Canada; Cardiovascular Diseases; Humans; Nicotinic Agonists; Publications; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline | 2013 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Benzazepines; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; England; Female; General Practice; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Commentary on "The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey" by Enger et al.
Topics: Benzazepines; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Risk Management; Smoking Cessation; Varenicline | 2013 |
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
Topics: Benzazepines; Breath Tests; Carbon Monoxide; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
An unusual pattern of ligand-receptor interactions for the α7 nicotinic acetylcholine receptor, with implications for the binding of varenicline.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Nicotinic Agonists; Oocytes; Pyridines; Quinoxalines; Rats; Varenicline; Xenopus laevis | 2013 |
[Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
Topics: Acute Coronary Syndrome; Arthritis, Rheumatoid; Benzazepines; Electrocardiography; Female; Humans; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2014 |
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Topics: Animals; Ataxia; Benzazepines; Cerebellum; Dose-Response Relationship, Drug; Gait; Male; Mecamylamine; Motor Activity; Nerve Degeneration; Neural Pathways; Niacinamide; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Olivary Nucleus; Postural Balance; Pyridines; Quinoxalines; Rats; Rotarod Performance Test; Varenicline | 2013 |
Method development, validation and bioequivalence of varenicline in human plasma by liquid chromatography tandem mass spectrometry.
Topics: Benzazepines; Chromatography, Liquid; Clarithromycin; Humans; Linear Models; Quinoxalines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency; Varenicline | 2013 |
PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
Topics: 2,2'-Dipyridyl; Adult; Animals; Azabicyclo Compounds; Benzazepines; Binding, Competitive; Brain; Female; Humans; Kinetics; Ligands; Male; Middle Aged; Nicotine; Nicotinic Agonists; Papio; Positron-Emission Tomography; Quinoxalines; Radiometry; Receptors, Nicotinic; Reproducibility of Results; Varenicline | 2013 |
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.
Topics: Alkaloids; Azocines; Behavior Therapy; Behavior, Addictive; Benzazepines; Humans; Meta-Analysis as Topic; Nicotinic Agonists; Quinolizines; Quinoxalines; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
Topics: Analysis of Variance; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Memory Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking; Varenicline | 2013 |
Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice.
Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Benzazepines; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Quinolizines; Quinoxalines; Varenicline | 2013 |
Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.
Topics: Adult; Aged; Benzazepines; Cross-Sectional Studies; Data Collection; Data Interpretation, Statistical; England; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Population; Prescription Drugs; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
[Results of a multidisciplinary program to quit smoking].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Care Team; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult | 2013 |
Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study.
Topics: Adolescent; Adult; Benzazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Maternal Exposure; Middle Aged; New Zealand; Pregnancy; Pregnancy Complications; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Time Factors; Varenicline | 2013 |
Photoallergic reactions to varenicline mimicking brachioradial pruritus.
Topics: Aged; Benzazepines; Dermatitis, Photoallergic; Drug Eruptions; Forearm; Humans; Male; Nicotinic Agonists; Pruritus; Quinoxalines; Varenicline | 2013 |
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Benzazepines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Partial Agonism; HEK293 Cells; Humans; Male; Membrane Potentials; Mice; Molecular Structure; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinolizines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2013 |
Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Infusion Pumps, Implantable; Male; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Varenicline | 2014 |
Varenicline, smoking cessation, and neuropsychiatric adverse events.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
The effects of varenicline on alcohol seeking and self-administration in baboons.
Topics: Alcohol Drinking; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Male; Papio; Quinoxalines; Self Administration; Varenicline | 2014 |
Summaries for patients. Does varenicline help people with depression quit smoking?
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Depression; England; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Impact of access restrictions on varenicline utilization.
Topics: Adult; Benzazepines; Cohort Studies; Databases, Factual; Female; Health Benefit Plans, Employee; Humans; Insurance Coverage; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Varenicline | 2013 |
How confidence intervals become confusion intervals.
Topics: Anticoagulants; Benzazepines; Cardiovascular Diseases; Confidence Intervals; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Uncertainty; Varenicline | 2013 |
Varenicline induced acute interstitial nephritis in the setting of idiopathic membranous glomerulonephritis.
Topics: Benzazepines; Diagnosis, Differential; Female; Glomerulonephritis, Membranous; Humans; Middle Aged; Nephritis, Interstitial; Nicotinic Agonists; Quinoxalines; Varenicline | 2013 |
Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.
Topics: Benzazepines; Carbon Monoxide; Carboxyhemoglobin; Carcinoembryonic Antigen; Combined Modality Therapy; Cough; Counseling; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vital Capacity | 2013 |
Effect of allopurinol on smoking.
Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase | 2013 |
The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
Topics: Animals; Benzazepines; Motor Activity; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Smoking Cessation; Varenicline | 2015 |
Varenicline-induced coronary thrombosis.
Topics: Adult; Benzazepines; Coronary Thrombosis; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Increasing the dose of varenicline in patients who do not respond to the standard dose.
Topics: Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Vomiting | 2013 |
Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
Topics: Animals; Benzazepines; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Feeding Behavior; Female; Macaca mulatta; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2014 |
Reassessing the safety of varenicline.
Topics: Benzazepines; Female; Humans; Male; Quinoxalines; Smoking Cessation; Suicidal Ideation; Tobacco Use Cessation Devices; Varenicline | 2013 |
[Smoking cessation program run by anesthesiologists in a preoperative clinic].
Topics: Anesthesiology; Benzazepines; Female; Humans; Male; Motivation; Nicotinic Agonists; Outpatient Clinics, Hospital; Patient Education as Topic; Preoperative Care; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bipolar Disorder; Bupropion; Clinical Trials as Topic; Follow-Up Studies; Humans; Motivational Interviewing; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
'Real-world' effectiveness of smoking cessation treatments: a population study.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2014 |
[Determination of varenicline in the preparation Champix® with the use of two-dimensional capillary electrophoresis in connection with UV detection].
Topics: Benzazepines; Electrolytes; Electrophoresis, Capillary; Quinoxalines; Varenicline | 2013 |
Sentiment analysis to determine the impact of online messages on smokers' choices to use varenicline.
Topics: Adult; Behavior Therapy; Benzazepines; Decision Making; Female; Humans; Male; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Media; Tobacco Use Cessation Devices; Varenicline | 2013 |
Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.
Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Oocytes; Protein Binding; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline; Xenopus laevis | 2014 |
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain | 2014 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Placebo controlled trials.
Topics: Benzazepines; Confounding Factors, Epidemiologic; Humans; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Research Design; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2014 |
Tobacco quitline outcomes by service type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; South Dakota; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2014 |
Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.
Topics: Alcohol Drinking; Animals; Benzazepines; Dopamine; Dose-Response Relationship, Drug; Ethanol; Male; Microinjections; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Structure-Activity Relationship; Varenicline | 2014 |
Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
Topics: Acoustic Stimulation; Acoustics; Analysis of Variance; Animals; Apomorphine; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Nicotine; Nicotinic Agonists; Prepulse Inhibition; Quinoxalines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Varenicline | 2014 |
General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Chronic Disease; Drug Therapy, Combination; Electronic Health Records; Female; General Practitioners; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Selection; Practice Patterns, Physicians'; Quinoxalines; Research Design; Retrospective Studies; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Young Adult | 2014 |
Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function.
Topics: Adult; Aged; Benzazepines; Endothelium, Vascular; Humans; Male; Middle Aged; Oxidative Stress; Quinoxalines; Smoking Cessation; Varenicline; Vasodilation | 2014 |
Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.
Topics: Animals; Benzazepines; Drug Repositioning; Models, Animal; Nicotine; Quinoxalines; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline; Zebrafish | 2014 |
Twelve weeks of smoking cessation therapy with varenicline increases the serum levels of apolipoprotein A-I only in the success group.
Topics: Apolipoprotein A-I; Benzazepines; Cholesterol, HDL; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2014 |
Varenicline is more effective in attenuating weight gain than nicotine patch 12 months after the end of smoking cessation therapy: an observational study in Japan.
Topics: Asian People; Benzazepines; Body Mass Index; Female; Humans; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Weight Gain | 2014 |
Treatment of depression in a former smoker with varenicline? A case report and discussion.
Topics: Benzazepines; Depression; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline | 2014 |
On-line column coupled isotachophoresis-capillary zone electrophoresis hyphenated with tandem mass spectrometry in drug analysis: varenicline and its metabolite in human urine.
Topics: Adult; Benzazepines; Electrophoresis, Capillary; Humans; Molecular Structure; Nicotinic Agonists; Quinoxalines; Sensitivity and Specificity; Tandem Mass Spectrometry; Varenicline | 2014 |
Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult | 2014 |
Association of out-of-pocket pharmacy costs with adherence to varenicline.
Topics: Aged; Benzazepines; Community Pharmacy Services; Drug Costs; Female; Health Expenditures; Humans; Linear Models; Logistic Models; Male; Medicare; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline | 2014 |
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors.
Topics: Alkaloids; Animals; Benzazepines; Conditioning, Operant; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Varenicline; Zebrafish | 2014 |
Understanding statistical hypothesis testing.
Topics: Adolescent; Adult; Benzazepines; Data Interpretation, Statistical; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Statistics as Topic; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2014 |
Tobacco smoking: options for helping smokers to quit.
Topics: Australia; Benzazepines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; General Practice; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Single dose varenicline may trigger epileptic activity.
Topics: Animals; Benzazepines; Brain; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Seizures; Varenicline | 2014 |
[Abstinence rates among varenicline are highest].
Topics: Benzazepines; Bupropion; Humans; Mental Disorders; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Acute generalized exanthematous pustulosis caused by varenicline.
Topics: Acute Generalized Exanthematous Pustulosis; Benzazepines; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2014 |
[Vareniklin: a safe treatment of tobacco dependency for cardiovascular patients].
Topics: Benzazepines; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
Topics: Aged; Aged, 80 and over; Benzazepines; Bupropion; Cardiovascular Diseases; Cohort Studies; Comorbidity; Female; Humans; Incidence; Male; Medicare; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; Varenicline | 2014 |
The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Cell Line, Tumor; Choline; Gene Duplication; Humans; Membrane Potentials; Mice; Nicotinic Agonists; Protein Multimerization; Protein Structure, Quaternary; Protein Subunits; Protein Transport; Quinoxalines; Rats; Schizophrenia; Sequence Deletion; Varenicline | 2014 |
The role of impulsivity in dropout from treatment for cigarette smoking.
Topics: Adult; Benzazepines; Case-Control Studies; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Delay Discounting; Female; Humans; Impulsive Behavior; Male; Middle Aged; Patient Dropouts; Personality; Personality Inventory; Quinoxalines; Recurrence; Smoking; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Efficacy of varenicline for smoking cessation in bipolar disorder.
Topics: Benzazepines; Bipolar Disorder; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2014 |
Permeability analysis of neuroactive drugs through a dynamic microfluidic in vitro blood-brain barrier model.
Topics: Amines; Animals; Benzazepines; Biological Transport; Blood-Brain Barrier; Cell Survival; Cells, Cultured; Coculture Techniques; Cyclohexanecarboxylic Acids; Endothelial Cells; Ethosuximide; Gabapentin; gamma-Aminobutyric Acid; Indoles; L-Lactate Dehydrogenase; Mice; Microfluidic Analytical Techniques; Neuroglia; Permeability; Piperidines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Sertraline; Sunitinib; Tetrahydronaphthalenes; Valine; Varenicline | 2014 |
Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; General Practice; Humans; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline | 2014 |
Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline.
Topics: Animals; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Smoking Cessation; Varenicline | 2015 |
Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats.
Topics: Animals; Benzazepines; Bupropion; Cholinergic Agents; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Reinforcement, Psychology; Varenicline | 2014 |
Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers.
Topics: Adult; Anxiety Disorders; Benzazepines; Bupropion; Cross-Sectional Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2015 |
Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis.
Topics: Adolescent; Adult; Age Distribution; Benzazepines; Databases, Factual; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Primary Health Care; Quinoxalines; Sexism; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2014 |
Repeating the same mistake.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
Topics: Benzazepines; Drug Administration Schedule; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Retreatment; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Funding a smoking cessation program for Crohn's disease: an economic evaluation.
Topics: Adult; Azathioprine; Benzazepines; Canada; Cost-Benefit Analysis; Crohn Disease; Directive Counseling; Female; Humans; Immunosuppressive Agents; Male; Models, Statistical; Nicotinic Agonists; Program Evaluation; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tumor Necrosis Factor-alpha; Varenicline | 2015 |
Concurrent access to nicotine and sucrose in rats.
Topics: Animals; Behavior, Addictive; Benzazepines; Conditioning, Operant; Male; Nicotine; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sucrose; Varenicline | 2015 |
Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world".
Topics: Adolescent; Adult; Benzazepines; Cohort Studies; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Patient Compliance; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Varenicline | 2014 |
Relative potency of varenicline or fluvoxamine to reduce responding for ethanol versus food depends on the presence or absence of concurrently earned food.
Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Operant; Eating; Ethanol; Fluvoxamine; Male; Nicotinic Agonists; Quinoxalines; Rats; Rats, Inbred Lew; Reinforcement, Psychology; Self Administration; Treatment Outcome; Varenicline | 2014 |
CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part I.
Topics: Aprepitant; Azepines; Benzazepines; Central Nervous System Agents; Drug Discovery; History, 20th Century; History, 21st Century; Humans; Indenes; Morpholines; Neurotransmitter Agents; Ondansetron; Quinoxalines; Triazoles; Varenicline | 2014 |
Varenicline and abnormal sleep related events.
Topics: Adult; Aggression; Benzazepines; Dreams; Drug Labeling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Parasomnias; Pharmacovigilance; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Somnambulism; Varenicline; World Health Organization | 2015 |
[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].
Topics: Alcoholism; Benzazepines; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Pilot Projects; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Varenicline | 2014 |
Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Apolipoproteins E; Benzazepines; Body Weight; Cardiovascular Diseases; Cholesterol; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Plaque, Atherosclerotic; Quinoxalines; Varenicline | 2014 |
Maintenance of tobacco cessation programmes in public hospitals in Catalonia, Spain.
Topics: Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Hospitalization; Hospitals, Public; Humans; Inpatients; Nicotinic Agonists; Personnel, Hospital; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
Topics: Allosteric Regulation; Allosteric Site; Animals; Benzazepines; Bridged Bicyclo Compounds, Heterocyclic; Calcium; CHO Cells; Cricetulus; Gene Expression; HEK293 Cells; Humans; Hydrogen Bonding; Molecular Docking Simulation; Nicotinic Agonists; Protein Binding; Protein Isoforms; Protein Structure, Secondary; Pyridines; Quinoxalines; Receptors, Nicotinic; Structural Homology, Protein; Torpedo; Transgenes; Varenicline | 2015 |
The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.
Topics: Animals; Benzazepines; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Nicotinic Agonists; Quinoxalines; Receptors, Serotonin, 5-HT3; Reflex, Startle; Schizophrenia; Sensory Gating; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Varenicline | 2015 |
Improving the success of treating tobacco smokers.
Topics: Benzazepines; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2015 |
Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.
Topics: Alcohol Drinking; Animals; Benzazepines; Conditioning, Psychological; Ethanol; Female; Male; Mice; Mice, Inbred DBA; Motor Activity; Quinoxalines; Varenicline | 2014 |
Treatment effects and placebo effects.
Topics: Benzazepines; Endpoint Determination; Humans; Nicotinic Agonists; Placebo Effect; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco, Smokeless; Treatment Outcome; Varenicline | 2015 |
Quantifying treatment effects in randomised controlled trials.
Topics: Benzazepines; Humans; Outcome Assessment, Health Care; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2015 |
[Effectiveness of Varenicline with counseling programs on smoking cessation in a targeted clinical setting in China].
Topics: Benzazepines; China; Counseling; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2014 |
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.
Topics: Animals; Azetidines; Benzazepines; Bungarotoxins; Cholinergic Agonists; Cholinergic Antagonists; Conotoxins; Female; Male; Motor Neurons; Picolines; Presynaptic Terminals; Protein Subunits; Pyridines; Quinoxalines; Receptors, Cholinergic; Turtles; Varenicline; Vestibular Nerve | 2015 |
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.
Topics: Adolescent; Adult; Australia; Benzazepines; Canada; Female; Gender Identity; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; United Kingdom; United States; Varenicline | 2015 |
Mental health effects of varenicline.
Topics: Benzazepines; Humans; Mental Disorders; Quinoxalines; Sleep Wake Disorders; Tobacco Use Cessation Devices; Varenicline | 2015 |
Varenicline-induced acute liver injury with jaundice.
Topics: Benzazepines; Chemical and Drug Induced Liver Injury; Female; Humans; Jaundice; Middle Aged; Nicotinic Agonists; Quinoxalines; Varenicline | 2015 |
[The latest information on the forefront of the campaign against tobacco].
Topics: Benzazepines; France; Health Promotion; Humans; Lung Neoplasms; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2015 |
[Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes].
Topics: Adult; Aged; Alcohol Abstinence; Alcoholism; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline; Young Adult | 2014 |
Use of nicotine replacement therapy and stop-smoking medicines in a national sample of Aboriginal and Torres Strait Islander smokers and ex-smokers.
Topics: Adolescent; Adult; Australia; Benzazepines; Community-Based Participatory Research; Female; Humans; Longitudinal Studies; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Nicotinic Agonists; Poverty; Prospective Studies; Quinoxalines; Sampling Studies; Surveys and Questionnaires; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2015 |
[Penis transplantation in South Africa. Risk of suicide using varenicline?].
Topics: Adult; Benzazepines; China; Communications Media; Graft Survival; Humans; Male; Penile Transplantation; Quinoxalines; Sexual Dysfunction, Physiological; Smoking Cessation; South Africa; Suicide; Transplant Recipients; Varenicline; Young Adult | 2015 |
Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study.
Topics: Accidents, Traffic; Adolescent; Adult; Aged; Benzazepines; Cohort Studies; Crime; Epidemiologic Methods; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2015 |
Formative Evaluation of a Text Messaging Intervention to Promote Varenicline Adherence Among Tobacco-Dependent Persons with HIV.
Topics: Adult; Benzazepines; Feasibility Studies; Female; Focus Groups; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Program Evaluation; Quinoxalines; Smoking Cessation; Text Messaging; Tobacco Use Disorder; Varenicline | 2015 |
[Varenicline to stop smoking progressively].
Topics: Benzazepines; Humans; Multicenter Studies as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Varenicline | 2015 |
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline | 2015 |
Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy.
Topics: Adult; Aged; Benzazepines; Brachial Artery; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Nitroglycerin; Quinoxalines; Recovery of Function; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; Ultrasonography; Varenicline; Vasodilation; Vasodilator Agents; Young Adult | 2015 |
Varenicline, combination NRT, and nicotine patch did not differ for smoking cessation at 6 mo.
Topics: Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2016 |
Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.
Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2016 |
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2017 |
Essential tobacco dependence medicines in 137 countries.
Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.
Topics: Benzazepines; Bupropion; Cohort Studies; Humans; Netherlands; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis.
Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2022 |
Bupropion for smoking cessation in adolescents.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2021 |
Varenicline (Chantix): The Smoking Cessation Medication Prescribers May Be Avoiding.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2022 |
Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
[Tobacco cessation treatment for people with schizophrenia].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Cohort Studies; Humans; Malaysia; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2022 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
Topics: Adult; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes.
Topics: Animals; Benzazepines; Bupropion; Goals; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Smoking Cessation Agents; Varenicline | 2023 |
Initiation of Varenicline in People Hospitalized for Acute Coronary Syndrome Who Smoke.
Topics: Acute Coronary Syndrome; Benzazepines; Bupropion; Cognition; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2023 |
Nicotine and Cytisine Embryotoxicity in the Experimental Zebrafish Model.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Varenicline; Zebrafish | 2023 |